Abbott LZ, Spicer T, Bryz-Gornia V, Kwok S, Sninksy J, Poiesz B. Design and uses of signature primer to detect carryover of amplified material. J Virolog Meth 1994;46:51-9.
Abbud RA, Finegan CK, Guay LA, Rich EA. Enhanced production of human immunodeficiency type 1 by in vitro-infected alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis 1995;172:859-63.
Aboulafia DM, Mitsuyasu RT, Miles SA. Syndeneic bone-marrow transplantation and failure to eradicate HIV. AIDS 1991;5:344.
Adams M, Lee T-H, Busch MP, Heitman J, Marshall GJ, Gjerset GF, Mosley JW, Transfusion Safety Study Group. Rapid freezing of whole blood or buffy coat samples for polymerase chain reaction and cell culture analysis: application to detection of human immunodeficiency virus in blood donor and recipient repositories. Transfusion 1993;33:504-8.
Aledort LM, Hilgartner MW, Pike MC, Gjerset GF, Koerper MA, Lian ECY, Lusher JM, Mosley JW, Transfusion Safety Study Group. Variability in serial CD4 counts and relation to progression of HIV-1 infection to AIDS in haemophiliac patients. Br Med J 1992;304:212-216.
Aledort LM, Operskalski EA, Dietrich SL, Koerper MA, Gjerset GF, Lusher JM, Lian ECY, Mosley JW, Transfusion Safety Study Group. Low CD4 counts in a study of transfusion safety. N Engl J Med 1993;328:441-442.
Almedia GD, Paroda CD, St. Jeor S, Ascensao JL. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 1994;83:370-6.
Amaral MC, Miles S, Kumar G, Nel AE. Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth. J Clin Invest 1993;92:848-57.
Ambrus JL, Poiesz BJ, Lillie MA, Stadler I, DiBerardino LA, Chadha KC. Interferon and interferon inhibitor levels in patients infected with Varicella-Zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex or Kaposi's sarcoma, and in normal individuals. Am J Med 1989;87:405-7.
Amin R, Wells K, Poiesz BJ. Antiretroviral therapy. Kaleidoscope, ed. S. Rassu, 1992, 9- 68.
Amin RM, Dean MT, Zaumetzer LE, Poiesz BJ. Virucidal efficacy of various lens cleaning and disinfecting solutions of HIV-1 contaminated contact lenses. AIDS Res Hum Retrovir 1991;7:403-8.
Anders RA, Gustafson M, Edens M, Limper AH, Leof EB. Pneumocystis carinii modulates cyclin-dependent kinase activity in a lung epithelial cell line. J Eukaryot Microbiol 1996;43:13S.
Anderson DW, Epstein JS, Lee TH, Lairmore MD, Saxinger C, Kalyanaraman VS, Slamon D, Parks W, Poiesz BJ, Pierik LT, Lee H, Montagna R, Roche PA, Williams A, Blattner W. Serological confirmation of human T-lymphotropic virus type 1 infection in healthy blood and plasma donors. Blood 1989;74:2585-91.
Anderson DW, Epstein JS, Pierik LT, Lee TH, Lairmore MD, Saxinger C, Kalyanaraman VS, Slamon D, Parks W, Poiesz BJ, Blattner W. Development by the Public Health Service of Criteria for Serological Confirmation of HTLV-I/II Infections. In Human Retrovirology: HTLV edited by William Blattner, Raven Press, 1990, 391-96.
Ansaldi-Balocco N, Cinadamore N, Barbera C. Liver transplant in children. Pediatr Med Chir 1989;11:379-383.
Antony VB, Hadley KJ, Roeske RW, Kachel DL, Martin WJ. Mechanism of action of inhaled pentamidine: enhanced release of oxidants by alveolar macrophages in vivo and in vitro. Clin Res 1990;38:135A.
Antony VB, Queener SF, Sparks JA, Martin WJ. Mechanism of action of inhaled pentamidine: Pentamidine-induced activation of alveolar macrophages and killing of Pneumocystis carinii. Am Rev Resp Dis 1991;143:716.
Antony VB. Alcohol induced inhibition of alveolar macrophage oxidant release in vivo and in vitro. Alcoholism. Clin Exper Res 1993;17:389-393.
Antony VB. Increased susceptibility to P. carinii in immunocompromised host. Role of chronic ethanol intake. Adv Biosci 1993;86:457-462.
Antony VB. Pleural mesothelial cells release a growth factor for fibroblasts. Eur Respir Rev 1993;3:156-158.
Antony VB. Recruitment of inflammatory cells to the pleural space chemotactic cytokines and MCP-1 in human pleural fluids. J Immunol 1993;151:7216-7223.
Arenzana-Seisdedos F, Virelizier JL, Rousset D, Clark-Lewis, et al. HIV blocked by chemokine antagonist. Nature 1996;383:400.
Atchison RE, Gosling J, Monteclaro FS, Franci C, et al. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 1996;274:1924-6.
Avraham H, Scadden D, Chi S, Wang Z, Broudy VC, Zsebo KM, Groopman JE. Interaction of human bone marrow fibroblasts with megakaryocytes: role of the c-kit ligand. Blood 1992;80:1679-1684.
Avraham H, Vannier E, Chi SY, Dinarello CA, Groopman JE. Cytokine gene expression and synthesis by human megakaryocytic cells. Int J Cell Cloning 1992;10:70-79.
Avraham H, Vannier E, Cowley S, Jiang S, Chi S, Dinarello CA, Zsebo KM, Groopman JE. Effects of stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 1992;79:365-371.
Babu PG, Rawal BD, Khayam-Bashi H, Vyas GN. Detection of exceedingly low levels of HIV Proviral DNA in multimillion peripheral blood cells by PCR. PCR Methods and Applications 1993;3:63-64.
Baggish MS, Poiesz BJ, Jonet D, Williamson P, Refai A. Presence of human immunodeficiency virus DNA in laser smoke. Laser Surg Med 1991;11:197-203.
Bailie MB, Stadiford TJ, Laichalk LL, Coffey MJ, Strieter R, Peters-Golden M. Leukotrine-deficient mice manifest enhanced lethality from Klebseilla pneumonia in association with decreased alveolar machrophage phagocytic and bactericidal activities. J Immunol 1996;157:5221-5224.
Baillou A, Janvier B, Mayer R, Kanki P, M'Boup S, Denis F, Goudeau A, Essex M, Barin F. Site-directed serology using synthetic oligopeptides representing the C-terminus of the external glycoproteins of HIV-1, HIV-2, or SIVMAC may distinguish subtypes among primate lentiviruses. AIDS Res Hum Ret 1991;7:767-771.
Baldwin GC, Golde SW, Widhopf GF, Economou J, Gasson JC. Identification and characterization of a low-affinity GM-GSF receptor on primary and cultured melanoma cells. Blood 1991;78:609-616.
Barth AI, Pollack AL, Altschuler Y, Mostov KE, Nelson WJ. NH2-terminal deletion of beta-caatenin results in stable colocaliztion of mutant beta-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion. J Cell Biol 1997;136:693-706.
Barton PA, Imlay MM, Flory CM, Warren JS. Role of intercellular adhesion molecule-1 in glucan-induced pulmonary granulomatosis in the rat. J Lab Clin Med 1996;128:181-193.
Bernas M, Enriquez J, Way D, Witte M, Ragland A, Bradley-Dunlop D, Fiala M. Absence of monoclonal antibody detectable Kaposi sarcoma-specific antigens on lesion-derived cultured cells. Life Sci 1993;52:663-668.
Beschorner WE, Baughman K, Turnicky RP, Hutchins GM, Rowe SA, Kavanaugh-McHugh AL, Suresch DL, Herskowitz A. HIV-associated myocarditis. Pathology and immunopathology. Am J Pathol 1990;137:1365-1371.
Bhatnagar PK, Busch MP, Huffman WF, Silvestri J, Truneh A, Ulrich PP, Vyas GN. Delineation of the binding regions of CD-4 for HIV and HLA class II antigens. Proceedings of the XI Peptide Symposium July 8, 1989, San Diego. Leiden: ESCOM, 1990;849-851.
Bierman FZ. Guidelines for diagnosis and management of cardiac disease in children with HIV infection. J Pediatr 1991;119(1[Pt 2]):S53-6.
Bishop PC, Boone D, Parker JW. Immunophenotypes by flow cytometry: A longitudinal study in health individuals. Diagnostic Clin Immunol 1988;5:232-240.
Blanc P, Hoffman P, Michaels JF, Bernard E, Vinti H. Morand P, Loubiere R. Cardiac involvement in carriers of the human immunodeficiency virus. Report of 38 cases. Ann Cardiol Angeiol (Paris) 1990;39:519-525.
Blanchard DG, Hagenhoff C, Chow LC, McCann HA, Dittrich HC. Reversibility of cardiac abnormalities in human immunodeficiency virus (HIV)-infected individuals: a serial echocardiographic study. J Am Coll Cardiol 1991;17:1270-1276.
Bonagura VR, Cunningham-Rundles SL, Schuval S. Dysfunction of natural killer cells in human immunodeficiency virus-infected children with or without Pneumocystis carinii pneumonia. J Pediatr 1992;121:195-201.
Boutelje J, Karlstrom AR, Hartmanis MG, Holmgren E, Sjogren A, Levine RL. Human immunodeficiency viral protease in catalytically active as a fusion protein: characterization of the fusion and native enzymes produced in Escherichia coli. Arch Biochem Biophys 1990;283:141-9.
Brettler DB, Forsberg A, Bolivar E, Brewster F, Sullivan JL. Growth failure as a prognostic indicator for progression to acquired immunodeficiency syndrome in children with hemophilia. J Peds 1990;117:584-588.
Brettler DB, Forsberg AD, Levine PH, Andrews CA, Baker S, Sullivan J. HIV virus isolation studies and antibody testing in household contacts and sexual partners of persons with hemophilia. Arch Int Med 1988;148:1299.
Brettler DB, Forsberg AD, Levine PH, Petillo J, Lamon K, Sullivan JL. Factor VIII: C concentrate purified from plasma using monoclonal antibodies: Human studies. Blood 1989;73:1859-1863.
Brettler DB, Somasundaran M, Forsberg AP, Kraus E, Sullivan JL. Silent human immunodeficiency virus type 1 infection: A rare occurrence in a high-risk heterosexual population. Blood 1992;80:2396-2400.
Brichacek B, Stevenson M. Quantitative competitive RNA PCR for quantitation of virion-associated HIV-1 RNA. Methods 1997;12:294-299.
Brichacek B, Swindell S, Janoff EN, Pirrucello S, Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis 1996;174:1191-1199.
Brightman BK, Davis BR, Fan H. Preleukemic hematopoietic hyperplasmia induced by Moloney murine leukemia virus is an indirect consequence of viral infection. J Virology 1990;64:4582-4584.
Brown DL, Sather S, Cheitlin MD. Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient. Am Heart J 1993;125(5 Pt 1):1439-1441.
Brown NA, Kovacs A, Lui CR, Hur C, Zaia JA, Mosley JW, Transfusion Safety Study Group. Prevalence of antibody to human herpesvirus 6 among blood donors infected with HIV. Lancet 1988;2:1146.
Buckley JD, Pike MC, Mosley JW, Transfusion Safety Study Group. Statistical approaches to evaluating prognostic indices in HIV infection. AIDS 1991;5:1398. Buhl R, Jaffe HA, Holrovd KJ, Wells FB, Mastrangeli A, Saltini C, Cantin AM, Crystal RG. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989;1:1294-1298.
Burt A, Dechairo BM, Koenig GL, Carter DA, White TJ, Taylor JW. Molecular markers reveal differentiation among isolates of Coccidioides immitis from California, Arizona and Texas. Mol Ecol 1997;6:781-786.
Busch MP, Glynn SA, Schreiber GB for the National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. Potential increased risk of virus transmission due to exclusion of older donors because of concern over Creutzfeldt-Jakob disease. Transfusion 1997;37:996-1002.
Busch MP, Korelitz JJ, Kleinman SH, Lee SR, AuBuchon JP, Schreiber GB and the Retrovirus Epidemiology Donor Study. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. Transfusion 1995;35:903-910.
Busch M, Laycock M, Kleinman S, Wages J, Kaplan J, Khabbaz R, Hollingsworth C and the REDS Study Group. Accuracy of supplementary testing for human-t-lymphotrophic virus (HTLV) types I and II in United States blood donors. Blood 1994;83:1143-8.
Busch M, Murphy E, Nemo G for the REDS Study Group. Association of HLTV-I and HTLV-II with mycosis fungoides: Implications for HTLV seropositive blood donors. N Engl J Med 1993;329:2035.
Busch MP, Donegan E, Stuart M, Mosley JW, Transfusion Safety Study Group. Donor HIV-1 p24 antigenaemia and course of infection in recipients. Lancet 1990;2:1342.
Busch MP, Eble B, Heilbron D, Vyas GN. Risk assessment of human immunodeficiency virus infection by transfusion of antibody-negative blood. N Engl J Med 1990;322:850-851.
Busch MP, Eble BE, Khayam-Bashi H, Heilbron D, Murphy EL, Kwok S, Sninsky J, Perkins HA, Vyas GN. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. N Engl J Med 1991;325:1-5.
Busch MP, El Amad Z, McHugh TM, Chien D, Polito A. Reliable confirmation and quantitation of HIV-1 using a recombinant-antigen immunoblot assay. Transfusion 1991;31:129-137.
Busch MP, Henrard DR, Hewlett IK, Mehaffey WF, Epstein JS, Allain J-P, Lee T-H, Mosley JW, Transfusion Safety Study Group. Poor sensitivity, specificity, and reproducibility of detection of HIV-1 DNA in serum by polymerase chain reaction. JAIDS 1992;5:872-877.
Busch MP, Kleinman SH, Williams AE, Smith JW, Ownby HE, Laycock ME, Lee LLL, Pau C-P, Schreiber GB and the Retrovirus Epidemiology Donor Study. Frequency of human immunodeficiency virus (HIV) infection among contemporary anti-HIV-1 and anti-HIV-1/2 supplemental test-indeterminate blood donors. Transfusion 1996;36:37-44.
Busch MP, Operskalski EA, Mosley JW, Stevens CE, Schiff ER, Kleinman SH, Lee H, Lee M, Harris M, Transfusion Safety Study Group. Epidemiologic background and long-term course of human immunodeficiency virus type 1-infected blood donors identified prior to routine laboratory screening. Transfusion 1994;34:858-864.
Busch MP, Perkins HA, Vyas GN. The risk of HIV-1 in screened blood donations. N Engl J Med 1991;325:1746-1747.
Busch MP, Taylor PE, Lenes BA, Kleinman SH, Stuart M, Stevens CE, Tomasulo PA, Allain J-P, Hollingsworth CG, Mosley JW, and the Transfusion Safety Study Group. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. N Engl J Med 1990;323:1308-1312.
Busch MP, Valinsky JE, Paglieroni T, Prince HE, Crutcher GJ, Gjerset GF, Operskalski EA, Charlebois E, Bianco C, Holland PV, Petersen LR, Hollingsworth CG, Mosley JW. Screening of blood donors for idiopathic CD4+ T-lymphocytopenia. Transfusion 1994;34:192-197.
Busch MP, Young MJ, Samson SM, Ward JW, Mosley JW, Perkins HA, Transfusion Safety Study Group. Risk of human immunodeficiency virus transmission by blood transfusions before the implementation of HIV-1 antibody screening. Transfusion 1991;31:4-11.
Byrnes JJ, Cowman R. DNA polymerase cofactor from rabbit bone marrow. J Cell Biochem Suppl 1989;13D:149.
Byrnes JJ. Differential sensitivity of bone marrow DNA polymerase alpha and delta to inhibition by dideoxyribonucleotides. Proceedings of V International Conference on DNA, pp 558, 1989.
Cammarosano C, Lewis W. Cardiac lesions in acquired immune deficiency syndrome (AIDS). J Am Coll Cardiol 1985;5:703-706.
Carratu L, Franceschelli S, Pardini CL, Kobayashi GS, Horvath I, Vigh L, Maresca B. Membrane lipid perturbation modifies the set point of the temperature of heat shock response in yeast. Proc Natl Sci USA 1996;93:3870-3875.
Carter DA, Burt A, Taylor JW, Koenig GL, White TJ. Clinical isolates of Histoplasma capsulatum from Indianapolis, Indiana, have a recombining population structure. J Clin Microbiol 1996;34:2577-2584.
Centers for Disease Control and U.S.P.H.S. Working Group. Guidelines for counseling persons infected with human t-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Ann Int Med 1993;18:448-54.
Centers for Disease Control. HIV seroprevalence among adults treated for cardiac arrest before reaching a medical facility--Seattle, Washington, 1989-1990. MMWR 1992;41:381-383.
Chakrabarti R, Engleman EG. Interrelationships between mevalonate metabolism and the mitogenic signaling pathway in T lymphocyte proliferation. J Biol Chem 1991;266:12216-12222.
Chaturvedi S, Newman SL. Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120. J Clin Invest 1997;100:1465-1474.
Chen W, Gigliotti F, Harmsen AG. Latency is not an inevitable outcome of infection with Pneumocystis carinii. Infect Immun 1993;61:5406-5409.
Chen W, Havell EA, Gigliotti F, Harmsen AG. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infect Immun 1993;61:97-102.
Chen W, Havell EA, Harmsen AG. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun 1992;60:1279-1284.
Chen W, Havell EA, Moldawar LL, McIntyre KW, Chizzonite RA, Harmsen AG. Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J Exp Med 1992;176:713-718.
Chen W, Mills JW, Harnsen AG. Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses. Int J Exp Pathol 1992;73:709-720.
Chen YA, Essex M. Identification of a recombinant HTLV-II envelope protein for serological detection of HTLV-II carriers. AIDS Res and Hum Retroviruses 1991;7:453-457.
Chen YA, Lee TH, Shaw GM, Murphy EL, Blattner WA, Essex M. Type-specific antigens for serologic discrimination of HTLV-1 and HTLV-II infection. Lancet 1990;336:1153-1155.
Chen YA, Okayama A, Lee TH, Tachibana N, Mueller N, Essex M. Sexual transmission of Human T-Cell Leukemia Virus Type 1 associated with the presence of the anti-tax antibody. Proc Natl Acad Sci USA 1991;88:1182-1186.
Chen YA, Zhang X-Q, Dahl CE, Samuel KP, Schooley RT, Essex M, Papas TS. Delineation of type-specific regions on the envelope glycoproteins of human T-cell leukemia viruses. J Immunol 1991;147:2368-2376.
Chow F-PR, Hamburger AW. In vivo evaluation of the anemia induced by adidothymidine (AZT) in a murine model of AIDS. Eur J Haematol 1991;47:91-97.
Chow F-PR, Hamburger AW. Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice. Ext Hematol 1992;20:245-250.
Chow F-PR, Sutton PA, Hamburger AW. Induction of thrombocytosis by azidothymidine is unique among dideoxynucleosides in normal and MAIDS mice. Blood 1991;78:148a.
Chowdhury IH, Potash MJ, Volsky DJ. Redefinition of tropism of common macrophage-tropic human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1995;11:1467-14771.
Coffey MJ, Phare SM, Kazanjian PH, Peters-Golden M. 5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus. J Immunol 1996;157:292-299.
Coffey MJ, Wheeler CS, Gross KB, Eschenbacher WL, Sporn PH, Peters-Golden M. Increased 5-lipoxygenase metabolism in the lungs of human subjects exposed to ozone. Toxicology 1996;114:187-197.
Coffey MJ, Woffendin C, Phare SM, Strieter RM, Markovitz DM. RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages. Am J Physiol 1997;272(5 Pt.1):1025-1029.
Cohen DA, Fitzpatrick EA, Hartsfield C, Gillespie MN, Avdiushko M, Kaplan AM. Pulmonary lymphoid cell activation and cytokine expression in murine ADIS-associated interstitial pneumonitis. Am J Respir Cell Mol Biol 1997;16:153-161.
Conant MA, Calabrese LH, Thompson SE, Poiesz BJ, Rasheed S, Hirsch RL, Meyerson LA, Kremer AB, Want C, Goldstein G. Maintenance of CD4+ cells by thymopentin in HIV infected patients: Results of a double-blind, placebo-controlled trial. AIDS 1992;6:1335-9.
Condos R, Rom WN, Schluger NW. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 1997;34:1513-1515.
Cooley TP, Kunches LM, Saunders CA, Ritter JK, Perkins CJ, McLaren C, McCaffrey RP, Liebman HA. Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trial. N Engl J Med 1990;322:1340-1345.
Cooley TP, Kunches LM, Saunders CA, Perkins CJ, Kelley SL, McLaren C, McCaffrey RP, Liebman HA. Treatment of AIDS and AIDS-related complex with 2',3'-dideoxyinosine given once daily. Rev Infect Dis 1990;12(S5):S552-560.
Coustere C, Mentre F, Sommadossi JP, Diasio RB, Steiner JL. A mathematical model of the kinetics of 5-fluorouracil and its metabolites in humans. Cancer Chemother & Pharmacol 1991;28:123-129.
Coutlee F, Saint-Antoine P, Olivier C, Vessous-Elbaz A, Voyer H, Berrada F, Begin P, Giroux L, Viscidi R. Discordance between primer pairs in the polymerase chain reaction for detection of human immunodeficiency virus type 1: A role for Taq polymerase inhibitors. J Infect Dis 1991;164:817-818.
Cowley SA, Groopman JE, Avraham H. Effects of transforming growth factor beta on megakaryocytic cell fusion and endomitosis. Int J Cell Cloning 1992;10:223-231.
Coyle T, Cynamon M, Blair D, Poiesz B. Changes in the lymphocyte count and lymphocyte subsets after splenectomy in Human Immunodeficiency Virus infection. Am J Hemat 1992;41:144-5.
Coyle TE, Spicer TS, Michalovic D, Poiesz BJ. Identification case report: Moderate hemophilia B Leyden; identification by polymerase chain reaction, sequencing and oligomer restriction. Am J Hemat 1994;46:234-40.
Craighead JE, Huber SA, Martin WB. Murine cytomegalovirus myocarditis. Eur Heart J 1991;12(Suppl D):69-72.
Craighead JE, Martin WB, Huber SA. Role of CD4+ (helper) T cells in the pathogenesis of murine cytomegalovirus myocarditis. Lab Invest 1992;66:755-761.
Cretton EM, Schinazi RF, McClure HM, Anderson DC, Sommadossi JP. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys. Antimicrob Agents & Chemother 1991;35:5.
Cretton EM, Sommadossi JP. Modulation of 3'-azido-3'deoxythymidine catabolism by probenecid and aceaminophen in freshly isolated rat hepatocytes. Biochem Pharmacol 1991;42:1475-1480.
Cretton EM, Xie MY, Bevan RJ, Goudgaon NM, Schinazi RF, Sommadossi JP. Catabolism of 3'-azido-3'-deoxyuridine in hepatocytes and liver microsomes, with evidence of formation of 3'-amino-3'-deoxythmidine, a highly toxic catabolite for human bone marrow cells. Molec Pharmacol 1991;39:258-266.
Cunningham-Rundles S, Chen C, Bussell JB, Blackenship C, et al. Human immune development: implications for congenital HIV infection. Ann NY Acad Sci 1993;693;20-34.
Cunningham-Rundles S, Yeger-Arbitman R, Edelson P, Sanders D, Giardina PV, Hilgartner MW. Experimental approach to the study of immune function in children with possible human immunodeficiency virus infection. J Clin Lab Anal 1990;4:399-404.
D'Ettorre C, Levine RL. Reactivity of cysteine-67 of the human immunodeficiency virus-1 protease: studies on a peptide spanning residues 59 to 75. Arch Biochem Biophys 1994;313:71-6.
Da-Lu C, Qui Z, Byrnes JJ. PCNA stimulated DNA polymerase from bone marrow. Blood 1990;76:10.
Davis BR, Schwartz DH, Marx JC, Johnson CE, Berry JM, Lyding J, Merigan TC, Zander A. Absent or rare human immunodeficiency virus infection of bone marrow stem/progenitor cells in vivo. J Virol 1991;65:1985-1990.
Davis BR, Young NS. Suppression of hemopoiesis by viruses: A review. Ann NY Acad Sci 1991;628:282-286.
Deer T, Rosencrance JG, Chillag SA. Cardiac conduction manifestations of Reiter's syndrome. South Med J 1991;84:799-800.
De Stafano JA, Sleight RG, Babcock GF, Sramkoski RM, Walzer PD. Isolation of Pneumocystis carinii cysts by flow cytometry. Parasitol Res 1992;78:179-182.
De Stefano J, Walzer PD, Trinkle L, Cushion MT. Flow cytometric analysis of lectin binding to Pneumocystis carinii surface carbohydrates. J Parasitol 1992;78:271-280.
Diaz RS, Sabino EC, Mayer A, Mosley JW, Busch MP. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. J Virol 1995;69:3273-81.
Dietrich SL, Mosely JW, Lusher JM, Hilgartner MW, Operskalski EA, Habel L, Aledort LM, Gjerset GF, Koerper MA, Lewis BH, Pegelow CH, Transfusion Safety Study Group. Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Vox Sang 1990;59:129-135.
Dietrich W, Spannagl M, Schramm W, Vogt W, Barankay A, Richter JA. The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;102:505-514.
DiPersio JF, Hedvat C, Ford CF, Golde DW, Gasson JC. Characterization of the soluble human granulocyte-macrophage colony-stimulating factor receptor complex. J Biol Chem 1991;266:279-286.
Donegan E, Busch MP, Galleshaw JA, Shaw GM, Mosley JW, Transfusion Safety Study Group. Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. Ann Intern Med 1990;113:555-556.
Donegan E, Lee H, Operskalski EA, Shaw G, Kleinman S, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG, Mosley JW, Transfusion Safety Study Group. Transfusion transmission of retroviruses: human T lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion 1994;34:478-483.
Donegan E, Lenes BA, Tomasulo PA, Mosley JW, Transfusion Safety Study Group. Transmission of HIV-1 by component type and duration of shelf storage before transfusion. Transfusion 1990;30:851-852.
Donegan E, Pell P, Lee H, Shaw GM, Mosley JW, Transfusion Safety Study Group. Transmission of human T-lymphotropic virus type I by blood components from a donor lacking anti-p24: a case report. Transfusion 1992;32:68-91.
Donegan E, Stuart M, Niland JC, Sacks HS, Azen SP, Dietrich SL, Faucett C, Fletcher MA, Kleinman SH, Operskalski EA, Perkins HA, Pindyck J, Schiff ER, Stites DP, Tomasulo PA, Mosley JW, Transfusion Safety Study Group. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann Intern Med 1990;113:733-739.
Dosik H, Goldstein M, Poiesz BJ, Williams L, Fahnrich B, Ehrlich GD, Dunn I, Levine PH. Seroprevalence of human T-lymphotropic virus in blacks from a selected central Brooklyn population. Cancer Invest 1994;12:289-95.
Du B, Wolf A, Lee S, Terwilliger E. Changes in the host range and growth potential of an HIV-1 clone are conferred by the vpu gene. Virology 1993;195:260-4.
Dube DF, Sherman MP, Saksena NK, Bryz-Gornia V, Mendelson J, Love J, Arnold CB, Spicer T, Dube S, Glaser JB, Williams AE, Nishimura M, Jacobson S, Ferrer JF, DelPino N, Quiruelas S, Poiesz BJ. Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J Virol 1993;67:1175-84.
Dube DK, Dube S, Ersenoy S, Jones B, Bryz-Gornia V, Spicer T, Love J, Saksena N, Lechat MF, Shrazer DI, Dosik H, Glaser J, Levis W, Blattner W, Montagna R, Blumberg BS, Poiesz BJ. Serological and nucleic acid analyses for HIV and HTLV infection on archival human plasma samples from Zaire. Virology 1994;202:379-89.
Dube DK, Dube S, Sherman MP, Love J, Saksena NK, Harrington WJ, Ferrer JF, Papsidero L, Dyster L, Yanagihara R, Williams AE, Glaser JB, Herve VMA, Barre-Sinoussi F, Blumberg BS, Poiesz BJ. Estimation of genetic heterogeneity in primate T-cell lymphoma/leukemia viruses by Methods in Neuroscience: PCR in Neuroscience. Ed. G Sarkar, Academic Press, Inc, 1995;26:358-80.
Dube S, Paul B, Bryz-Gornia V, Stephens C, Erensoy S, Dube DK, Poiesz BJ. Use of PCR in the detection of antisense transcripts of HTLV-I infected patients and human T-cell lines. Methods In Neuroscience: PCR in Neuroscience. Ed. G Sarkan, Academic Press, Inc, 1995;26:381-400.
Dube S, Spicer T, Bryz-Gornia V, Jones B, Dean T, Love J, Ferrer J, Harrington W, Glaser J, Dube D, Williams A, Dosik H, Seigal F, Poiesz BJ. A rapid and sensitive method of identification of HTLV-II subtypes. J Med Virol 1995;45:1-9.
Dugel PU, Gill PS, Frangieh GT, Rao NA. Treatment of ocular adnexal Kaposi's sarcoma in acquired immune deficiency syndrome. Ophthalmology 1992;99:1127-1132.
Duggan DB, Santarelli MT, Zamkoff, Lichtman S, Ellerton J, Cooper R, Poiesz B, Peterson B, Gottlieb A. A phase II study of recombinant IL-2 with or without recombinant interferon-B in non-Hodgkin's lymphoma. A study of the cancer and leukemia group. Brit J Immunother 1992;12:115-22.
Dupuy JM, Gilmore N, Goldman H, Tsoukas C, Pekovic D, Chausseau JP, Duperval R, Joly M, Pelletier L, Thibaudeau Y. Thymic epithelial cell transplantation in patients with acquired immunodeficiency syndrome. Evidence for infection by HIV-I of newly differentiated T cells at the site of transplantation. Thymus 1991;17:205-218.
Dyster LM, Poiesz BJ, Abbott L, Bryz-Gornia V, Papsidero LD. Evaluation of enzyme oligonucleotide assays for the specific detection of HIV-1, HTLV-I and HTLV-II DNA following gene amplification. J Clin Microbiol 1994;32:547-50.
Eble BE, Busch MP, Khayam-Bashi H, Nason MA, Samson S, Vyas GN. Resolution of infections status of HIV-seroindeterminate donors and high-risk seronegative individuals using PCR and virus-culture: absence of persistent silent HIV-1 infection in a high-prevalence area. Transfusion 1992;32:503-508.
Edwards VM, Mosley JW, Transfusion Safety Study Group. Reproducibility in quality control of protein (Western) immunoblot assay for antibodies to human immunodeficiency virus. Am J Clin Path 1989;91:75-78.
Ehrlich GD, Andrews J, Sherman MP, Greenberg SJ, Poiesz BJ. DNA sequence analysis of the gene encoding the HTLV-I p21E transmembrane protein reveals inter- and intraisolate genetic heterogeneity. Virology 1992;186:619-27.
Ehrlich GD, Glaser JB, Bryz-Gornia V, Maese J, Waldmann TA, Poiesz BJ, Greenberg SJ and the HTLV-MS Working Group. Multiple sclerosis, retroviruses and PCR. Neurology 1991;412:335-43.
Ehrlich GD, Glaser JB, LaVigne K, Quan D, Mildvan D, Sninsky JJ, Kwok S, Papsidero L, Poiesz BJ. Prevalance of human T-cell leukemia/lymphoma virus (HLTV) Type II infection among high-risk individuals: Type-specific identification of HTLVs by polymerase chain reaction. Blood 1989;74:1658-1664.
Ehrlich GD, Glaser JB, Abbott MA, Slamon D, Keith D, Sliwkowski M, Brandis J, Keitelman E, Teamoto Y, Papsidero L, Simpkins H, Sninsky JJ, Poiesz BJ. Detection of anti-HLTV-I Tax antibodies in HTLV-I enzyme-linked immunosorbent assay-negative individuals. Blood 1989;74:1066-72.
Esposito TJ, Jurkovich GJ, Rice CL, Maier RV, Copass MK, Ashbaugh DG. Reappraisal of emergency room thoracotomy in a changing environment. J Trauma 1991;31:881-887.
Essex M, Kanki P, Marlink R, Chou MJ, Lee TH. Antigenic characterization of the human immunodeficiency viruses. J Amer Acad Dermatol 1990;22:1206-1209.
Ezekowitz RAB. The mannose receptor and phagocytosis. In Mononuclear Phagocytes, ed. R van Furth, Kluwer Academic Publishers, Dordrecht, 1992;208-213.
Fabian I, Kletter Y, Mor S, Geller-Bernstein C, Ben-Yaakov M, Volovitz B, Golde DW: Activation of human eosinophil and neutrophil functions by haematopoietic growth factors: comparisons of IL-1, IL-3, IL-5 and GM-CSF. Br J Haematol 1992;80:137-143.
Fabian I, Lass M, Kletter Y, Golde DW. Differentiation and functional activity of human eosinophilic cells from an eosinophil HL-60 subline: Response to recombinant hemotopoietic growth factors. Blood 1992;80:788-794.
Fagnoni FF, Takamizawa M, Godfrey WR, Rivas A, Azuma M, Okumura K, Engleman EG. Role of B70/B7-2 in CD4+ T-cell immune responses induced by dendritic cells. Immunology 1995;85:467-74.
Fan N, Gavalchin J, Paul B, Wells K, Lane M, Poiesz B. Infection of peripheral blood mononuclear cells by cell free human t-cell lymphoma virus (HTLV-I). J Clin Microbiol 1992;30:905-10.
Ferrer JF, Sherman MP, Esteban E, Quiruelas S, Basombrio MA, Dube S, Dube DF, Pimental E, Scgovia A, Poiesz BJ, DelPino N. High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of Argentina. Virology 1993;197:576-84.
Fiebig EW, Johnson DK, Hirschkorn DF, Knape CC, Webster HK, Lowder J, Busch MP. Lymphocyte subset analysis on frozen whole blood. Cytometry 1997;29:340-350.
Fischl MA, Krown SE, O'Boyle KP, Mitsuyasu R, Miles SA, Wernz JC, Volberding PA, Kahn J, Groopman JE, Feinberg J, Woody M and the AIDS Clinical Trials Group. Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trial Group. J Acquir Immune Defic Syndr 1993;6:259-264.
Fisher DJ, Gigliotti F, Zauderer M, Harmsen AG. Specific T-cell response to a Pneumocystis carinii surface glycoprotein (gp120) after immunization and natural infection. Infect Immun 1991;59:3372-3376.
Fitzpatrick EA, Kaplan AM, Cohen DA. Defective CD4+ cell signaling in murine ADIS: uncoupling of the T cell receptor complex from PIP2 hydrolysis. Cell Immunol 1996;167:176-187.
Fleming AF. Tropical obstetrics and gynecology. 1. Anemia in pregnancy in tropical Africa. Trans R Soc Trop Med Hyg 1989;83:441-448.
Fletcher MA, Azen SP, Adelsberg B, Gjerset GF, Hassett J, Kaplan J, Niland JC, Odom-Maryon T, Parker JW, Stites DP, Mosely JW, Transfusion Safety Study Group. Immunophenotyping in a multicenter study: the Transfusion Safety Study experience. Clin Immunol Immunopathol 1989;52:38-47.
Fletcher MA, Baron GC, Ashman MR, Fischl MA, Klimas NG. The use of whole blood methods in assessment of immune parameters in immuno-deficiency states. Diagn Clin Immunol 1987;5:69-81.
Fletcher MA, Gjerset GF, Hassett J, Donegan E, Parker JW, Mosley JW, Transfusion Safety Study Group. Lymphocyte immunophenotypes among anti-HTLV-I/II-positive blood donors and recipients. JAIDS 1991;4:628-632.
Fletcher MA, Mosley JW, Hassett J, Gjerset GF, Kaplan J, Parker JW, Donegan E, Lusher JM, Lee H, Transfusion Safety Study Group. Effect of age on HIV-1 induced changes in lymphocyte populations among persons with congenital clotting disorders. Blood 1992;80:831-840.
Flomenbaum M, Soeiro R, Udem SA, Kress Y, Factor SM. Proliferative membranopathy and human immunodeficiency virus in AIDS hearts. J Acquir Defic Syndr 1989;2:129-135.
Flynn TE, Reppucci VS, McKinley G, Potash MJ, Volsky DJ. Detection of HIV-1 in surgical specimens from vitreous of AIDS patients. AIDS 1995;9:1103-1104
Francis CK. Cardiac involvement in AIDS. Curr Probl Cardiol 1990;15:569-639.
Frickhofen N, Abkowitz JL, Safford M, Berry M, Antunez-de-Mayolo J, Astrow A, Cohen R, Halperin I, King L, Mintzer D, Cohen B, Young N. Persistant B19 parovirus infection in patients infected with Human Immunodeficiency Virus Type 1 (HIV-1): A treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926-933.
Frickhofen N, Young NS. Polymerase chain reaction for detection of parvovirus B19 in immunodeficient patients with anemia. Behring Inst Mitt 1990;85:46-54
Friedman H, Kurec A, Goldberg J, Coyle T, Poiesz B, Forbes B. Large granular lymphocytosis terminating in a polymorphous B lymphocytic proliferation: a case report with necropsy findings. Hemat Path 1992;6:209-18.
Friedman HD, Hutchinson RE, Smith JR, Gonchoroff NJ, Stein CF, Poiesz BJ. Polyobulated T-cell leukemia/lymphoma; a case report with immunophenotypic ultrastructural, genomic and DNA content analysis. Archiv Path Lab 1994;118:722-7.
Friedman HD, Inmun DA, Hutchinson RA, Poiesz BJ. Concurrent invasive thymoma and T-cell lymphoblastic leukemia/lymphoma: a case report with necropsy findings and literature review of thymoma and associated hematologic neoplasms. Am J Clin Path 1994;101:432-7.
Furlong ST, Gorti R, Catalano PJ, Rose RM. Lipid content of alveolar lining material collected by bronchoalveolar lavage: Improved methods for measuring the major lipid classes. Am Rev Respir Dis 1992;145:383-387.
Furlong ST, Mednis A, Remold HG. Interferon stimulates lipid metabolism in human monocytes. Cell Immuno 1992;143:108-117.
Gan H, Newman G, McCarthy PL, Remold HG. TNF- response of human monocyte-derived macrophage to Mycobacterium avium, serovar 4, is of brief duration and protein kinase C dependent. J Immunol 1993;150:1-9.
Garvy BA, Ezekowitz RA, Harmsen AG. Role of gamma interferon in the host immune and inflammatory responses to Pneumoystis carinii infection. Infect Immun 1997;65:373-379.
Garvy BA, Harmsen AG. The role of T cells in infection-driven intersstitial pneumonia after bone marrow transplantation in mice. Transplantation 1996;62:517-525.
Garvy BA,Harmsen AG. Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults. Infect Immun 1996;64:3987-3992.
Gavalchin J, Fan N, Lane MJ, Papsidero L, Poiesz B. Identification of putative cellular receptor for HTLV-I by a monoclonal antibody, Mab23-34. Virology 1993;194:1-9.
Gawrisch K, Han KH, Yang JS, Bergelson LD, Ferretti JA. Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type I with lipid bilayers. Biochemistry 1993;32:3112-8.
Gendelman HE, Ehrlich GD, Baca LM, Conley S, Ribas J, Kalter DC, Meltzer MS, Poiesz BJ, Nara P. The inability of human immunodeficiency virus to infect chimpanzee monocytes can be overcome by serial viral passage in vivo. J Vir 1992;65:3853-63.
Gigliotti F, Garvy BA, Harmsen AG. Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pnuemocystis carinii pneumonia. Infect Immun 1996;64:1892-1899.
Gigliotti F, Haidaris PJ, Haidaris CG, Wright TW, Van Der Meid KR. Further evidence of host species-specific variation in antigens of Pneumocystis carinii using the polymerase chain reaction (PCR). J Infect 1993;168:191-194.
Gigliotti F, Harmsen AG, Haidaris CG, Haidaris PJ. Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun 1993;61:2886-2890.
Gill PS, Bernstein-Singer M, Espina BM, Rarick M, Magy F, Montgomer T, Berry MS, Levine A. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. AIDS 1992;6:1477-1481.
Gill PS, Miles SA, Mitsuyasu RT, Montgomery T, McCarthy S, Espina BM, Feldstein M, Levine AM. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma. AIDS 1994;8:1695-9.
Gill PS, Rarick M, McCutchan JA, Slater L, Parker B, Muchmore E, Bernstein-Singer M, Akil B, Espina BM, Krailo M, Levine A. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med 1991;90:427-433.
Gill PS. Pathogenesis of HIV-related malignancies. Curr Opin Oncol 1991;3:867-871.
Gill PS. Phase I/II trials of alpha-interferon alone or in combination with zidovudine as maintenance therapy following induction chemotherapy in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. Semin Oncol 1991;18:S53-S57.
Gjerset G, Vyas GN, Bhat R, Operskalski EA, Transfusion Safety Study Group. Phenotypes for group-specific component among patients exposed to human immunodeficiency virus by transfusions. J Infect Dis 1988;157:609-610.
Gjerset GF, Pike MC, Mosley JW, Hassett J, Fletcher MA, Donegan E, Parker JW, Counts RB, Zhou Y, Kasper KC, Operskalski EA, Transfusion Safety Study Group. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Blood 1994;84:1666-1671.
Glaser JB, Levis WB, Gruber T, Celbreva A, Poiesz BJ. Prevalence of human T-cell lymphotropic virus (HTLV) types I and II and human immunodeficiency virus type II infections among persons with Hansen's disease in New York City. J Infect Dis 1994;170:1007-9.
Glassroth J, Jordan M, Wallace JM, Kvale PA, Follmann DA, Rosen MJ, Reichman LE, Mossar M, Hopewell PC and the Pulmonary Complications of the HIV Study Group. Use of preventive interventions by persons infected with type-1 human immunodeficiency virus (HIV-1). The Pulmonary Complications of HIV Study Group. Am J Prev Med 1994;10:259-66.
Golde DW. Host defense: the new medical frontier. Congressional Record, Issue No. 101, E 2407, Proceedings of June 27, 1991.
Golde DW. The stem cell. Sci Am 1991;266:86-93.
Golden MP, Kim S, Hammer SM, Ladd EA, Schaffer PA, DeLuca N, Albrecht MA. Activation of HIV by herpes simplex virus. J Infect Dis 1992;166:494-499.
Gonzalez-Scarano F, Waxham MN, Ross AM, Hoxie JA. Sequence similarities between human immunodeficiency virus gp41 and paramyoxovirus fusion proteins. AIDS Res Hum Retroviruses 1987;3:245-252.
Gorman CM, Aikawa M, Fox B, Fox E, Lapuz C, Michaud B, Nguyen H, Roche E, Sawa T, Wiener-Kronish JP. Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC. Gene Ther 1997;4:983-992.
Govindarajan S, Edwards VM, Stuart ML, Operskalski EA, Mosley JF, Transfusion Safety Study Group. Influence of human immunodeficiency virus infection upon expression of chronic hepatitis B and D virus infections. In: Zuckerman AJ (ed), Viral Hepatitis and Liver Disease, Alan R. Liss, Inc., New York, NY, pp 210-214, 1988.
Graves KL, Roman J. Fibronectin modulates expression of interleukin-1 beta and its receptor antagonist in human mononuclear cells. Am J Physiol 1996;271(1 Pt. 1):L61-69.
Greenberg S, Jaffe E, Ehrlich G, Korman N, Poiesz B, Waldman T. Kaposi's sarcoma in human T-cell leukemia virus type I associated adult T-cell cell leukemia. Blood 1990;76:971-6.
Greenberg SJ, Ehrlich GD, Abbott MA, Hurwitz BJ, Waldman TA, Poiesz BJ. Detection of exogenous sequences homologous to human retroviral DNA in multiple sclerosis by gene amplification. Proc Natl Acad Sci 1989;86:2878-82.
Grody WW, Cheng L, Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol 1990;66:203-206.
Guadiz G, Sporn LA, Goss RA, Lawrence SO, Marder VJ, Simpson-Haidaris PJ. Polarized secretion of fibrinogen by lung epithelial cells. Am J Respir Cell Biol 1997;17:60-69.
Guadiz G, Sporn LA, Simpson-Haidaris PJ. Thrombin cleavage-independent deposition of fibrinogen in extraccellular matrices. Blood 1997;90:2644-2653.
Guay LA, Sierra-Madero JG, Finegan CK, Rich EA. Mediation of entry of human immunodeficiency virus-1 into alveolar macrophages by CD4 without facilitation by surfactant-associated protein-A. Am J Respir Cell Mol Biol 1997;16:421-428.
Gurley RJ, Ikeuchi K, Byrn RA, Anderson K, Groopman JE. CD4+ lymphocyte function with early human immunodeficiency virus infection. Proc Natl Acad Sci USA 1989;86:1991-1997.
Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA 1994;91:10732-6.
Gyetko MR, Chen GH, McDonald RA, Goodman R, Huffnagle GB, Wilkinson CC, Fuller JA, Toews GB. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J Clin Invest 1996;97:1818-18226.
Haidaris PJ. Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood 1997;89:873-882.
Haidaris PJ. In situ hybridization analysis of developmental stages of Pneumocystis carinii that are transcriptionally active for a major surface glycoprotein gene. Mol Microbiol 1993;7:647-656.
Haidaris PJ, Wright TW, Gigliotti F, Haidaris CG. Expression and characterization of a cDNA clone encoding an immunodominant surface glycoprotein of Pneumocystis carinii. J Infect Dis 1992;166:1113-1123.
Hamilton AS, Radka SF, Bernstein L, Gill PS, Gonsalves M, Naemura JR, Ross RK. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma. J Acquir Immune Defic Syndr 1994;7:410-414.
Hammer SM, Gillis JM, Groopman JE, Rose RM. In vitro modification of human immunodeficiency virus infection by granulocyte-macrophage colony-stimulating factor and interferon. Proc Natl Acad Sci USA 1986;83:8734-8738.
Harmsen AG. Requirement for CD4 cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990;172:937-945.
Harmsen AG. Resolution of Pneumocystis carinii pneumonia in CD4 lymphocyte-depleted mice given aerosois of heat treated Escherichia coil. J Exp Med 1992;176:881-886.
Harmsen AG. T cells are not sufficient for resistance to Pneumocystis carinii pneumonia in mice. J Protozool 1991;38:S44-S45.
Harrington WJ, Lian E, Temple JD, Rabin M, Miller G, Harrington T, Byrnes JJ. Retroviral associated thrombotic thrombocytopenic purpura. Blood 1990;76S:487a.
Harrington WJ, Sheremata W, Hjelle B, Dube DK, Bradshaw P, Foung SKH, Snodgrass S, Toedter G, Cabral L, Poiesz BJ. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993;33:411-4.
Harrington WJ, Ucar A, Gill P, Snodgrass S, Sheremata W, Rabin M, Byrne G, Cabral L, Berger J, Voight W, Kemper B, Miller G, Whitcomb C, Greenberg A, Byrnes JJ, Poiesz BJ. Clinical spectrum of HTLV-I in South Florida. J Aids 1995;8:466-73.
Harris NS, Super M, Rits M, Chang G, Ezekowitz RAB. Characterization of the murine macrophage mannose receptor: Demonstration that the downregulation of receptor expression mediated by interferon-ç occurs at the level of transcription. Blood 1992;80:2363-2373.
Hartman DL. Pleurdesis. Now what should we use? J Respir Dis 1993;14:347-351.
Hartsfield CL, Lipke D, Lai YL, Cohen DA, Gillespie MN. Pulmonary mechanical and immunologic dysfunction in a murine model of AIDS. Am J Physiol 1997;272(4 Pt. 1):L699-706.
Hassett J, Gjerset GF, Mosley JW, Fletcher MA, Donegan E, Parker JW, Counts RB, Aledort LM, Lee H, Pike MC, Transfusion Safety Study Group. Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. Blood 1993;82:1351-7.
Hellinger JA, Essex M. Human immunodeficiency virus and other retroviruses. In: Infectious Diseases in Medicine and Surgery, eds., Gorbach, Bartlett, and lacklow, WB Saunders, pp. 1797-1824, 1991.
Heneine W, Switzer WM, Busch M, Khabbaz RF, Kaplan JE. Molecular subtyping of human T-cell lymphotropic virus type 2 by single-strand conformation polymorphism analysis. Retrovirus Epidemiology Donor Study Group. J Clin Microbiol 1995;33:3260-3263.
Henry DH, Jemsek JG, Levin AS, Levine JD, Levine RL, Abels RI, Nelson RA, Thompson D, Rudnick SA. Recombinant human erythropoietin and the treatment of anemia in patients with AIDS or advanced ARC not receiving ZDV. J Acquir Immune Defic Syndr 1992;5:847-8.
Hersh EM, Brewton G, Abrams D, Bartlett J, Galpin J, Gill P, Gorter R, Gottlieb M, Jonikas JJ, Landesman S, Levine A, Marcel A, Petersen E, Whiteside M, Zahradnik J, Negron C, Boutitie F, Caraux J, Dupuy JM, Salmi R. Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study. JAMA 1991;265:1538-1544.
Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman SP, Neumannn DA, Baughman KL. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. Am J Cardiol 1993;71:955-958.
Herskowitz A, Willoughby S, Wu TC, Beschorner WE, Neumann DA, Rose NR, Baughman KL, Ansari AA. Immunopathogenesis of HIV-1-associated cardiomyopathy. Clin Immunol Immunopathol 1993;68:234-241.
Herskowitz A, Willoughby SB, Baughman KL, Schulman SP, Bartlett JD. Cardiomyopathy associated with antiretroviral therapy in patients with HIV infection: a report of six cases. Ann Intern Med 1992;116:311-313.
Hewitt RG, Morse GD, Lawrence WD, Maliszewski ML, Santora J, Bartos L, Bonnen E, Poiesz BJ. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex. Anti-microb Agents Chemother 1993;37:512-22.
Hilgartner MW, Buckley JD, Operskalski EA, Pike MC, Mosley JW, Transfusion Safety Study Group. Purity of factor VIII concentrates and serial CD4+ counts. The Transfusion Safety Study Group. Lancet 1993;341:1373-4.
Himelman RB, Chung WS, Chernoff DN, Schiller NB, Hollander H. Cardiac manifestations of human immunodeficiency virus infection: A two-dimensional echocardiographic study. J Am Coll Cardiol 1989;13:1030-5.
Himelman RB, Dohrmann M, Goodman P, Schiller NB, Starksen NF, Warnock M, Cheitlin MD. Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome. Am J Cardiol 1989;64:1396-1399.
Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, Markowitz N, Rosen MJ, Mangura BT, Hopewell PC, and the Pulmonary Complications of HIV Infection Study Group. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995;333:845-51.
Honig LS, Lipka JJ, Young KYY, Weiss JH, Foung SKH. HTLV-I-associated myelopathy in a Californian: Diagnosis by reactivity to a viral recombinant epitope. Neurology 1991;41:448-450.
Hott JW, Sparks JA, Godbey SW, Antony VB. Mesothelial cell migration response to chemoattractants: Chemotactic response of rat pleural mesothelial cells to thrombin. Am Rev Resp Dis 1991;143:658.
Hott JW, Sparks JA, Godbey SW, Antony VB. Mesothelial cell response to pleural injury. Thrombin-induced proliferation of rat pleural mesothelial cells. Clin Res 1991;39:179A.
Hoyte JS, Standing JE, Limper AH. Steady-state effects of vitronectin and fibronectin on the binding, uptake, and degradatin of Pneumocystis carinii in rat alveolar macrophages. Inflammation 1997;21:335-345.
Hsia J, Bradley G, Campbell D. Natural history of human immunodeficiency virus-associated heart disease. J Am Soc Echo 1991;4:300.
Hsia J, Colan SD, Adams S, Ross AM. Late potentials and their relation to ventricular function in human immunodeficiency virus infection. Am J Cardiol 1991;68:1216-1220.
Hsia J. Cardiac complications of HIV infection. Medical Aspects of Human Sexuality. 1990;3:60-65.
Hsia J. False-positive ELISA for human immunodeficiency virus after influenza vaccination. J Infect Dis 1993;167:989-990.
Hsia J. HIV-associated heart disease. In: Rehabilitation for Patients with HIV Disease, J Mukand, ed. McGraw-Hill, New York, 1991, p.95-118.
Huang ML, Essex M, Lee TH. Localization of immunogenic domains in the HIV-2 envelope. J Virol 1991;65:5073-5077.
Huang YQ, Li JJ, Kim K-S, Nicolaides A, Zhang WG, Le J, Poiesz BJ, Friedman-Kien A. HIV-1 infection and modulation of cytokine and growth factor expression in Kaposi's sarcoma-derived cells in vitro. AIDS 1993;7:317-22.
Huang YQ, Li JJ, Moscatelli D, Basilico C, Nicholaides A, Zhang WG, Poiesz BJ, Freidmen-Kien A. Expression of Int-2 oncogene in Kaposi's sarcoma lesions. J Clin Invest 1993;91:1191-7.
Huang YQ, Li JJ, Rush MG, Poiesz BJ, Nicholaides A, Zhang WG, Coutavas E, Abbott MA, Friedman-Kien AE. HPV-16-related DNA sequences in Kaposi's sarcoma. Lancet 1992;339:515-8.
Huang YQ, Li JJ, Zhang WC, Feiner D, Kaplan M, Poiesz BJ, Katabira E, Friedman-Kien AE. Prevalence of human herpes virus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995;345:759-61.
Huang Z-B, Potash MJ, Simm M, Shahabuddin M, Chao W, Gendelman HE, Eden E, Volsky DJ. Infection of macrophages with lymphotropic human immunodeficiency virus type 1 can be arrested after viral DNA synthesis. J Virol 1993;67:6893-6.
Huffnagle GB, Chen GH, Curtis JL, McDonald RA, Strieter RM, Toews GB. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J Immunol 1995;155:3507-3516.
Huffnagle GB, Strieter RM, Standiford TJ, McDonald RA, Burdick MD, Kunkel SL, Toews GB. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ cells during a pulmonary Cryptococcus neoformans infection. J Immunol 1995;155:4790-4797.
Huffnagle GB, Toews GB, Burdick MD, Boyd MB, McAllister KS, McDonald RA, Kunkel SL, Strieter RM. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J Immunol 1996;157:4529-4536.
Husmann LK, Dillehay DL, Jennings VM, Scott JR. Streptococcus pyogenes infection in mice. Microb Pathog 1996;20:213-224.
Iannone R, Sherman MP, Rodgers-Johnson PEB, Beike MA, Mora CA, Amin RM, Tinsley SR, Papsidero LD, Poiesz BJ, Gibbs CJ. HTLV-1 DNA sequences in Central Nervous System tissue of a patient with tropical spastic paraparesis and HTLV-1 associated myelopathy. JAIDS 1992;5:810-6.
Ireland-Gill A, Espina BM, Akil B, Gill PS. Treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma using bleomycin-containing combination chemotherapy regimens. Semin Oncol 1992;19:S32-S37.
Jackson JB, Drew J, Lin HJ, Otto P, Brewer J, Hollinger FB, Wolinsky S and the ACTG PCR Working Group. Establishment of a quality assurance program for human immunodeficiency virus type-1 DNA polymerase chain reaction assays in the AIDS Clinical Trials Group. J Clin Micro 1993;31:3123-8.
Jennings VM, Dillehay DL, Webb SK. Diagnostic exercise: hepatomegaly in an aged cynomolgus (Macaca fasicularis) monkey. Lab Anim Sci 1995;45:680-682.
Jennings VM, Dillehay DL, Webb SK, Brown LA. Pulmonary alveolar proteinosis in SCID mice. Am J Respir Cell Col Biol 1995;13:297-306.
Johnson D, Hirschkorn D, Busch MP and the REDS Group. Evaluation of four alternative methodologies for determination of absolute CD4+ lymphocyte counts. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:522-530.
Johnson JE, Slife DM, Anders GT, Bailey SR, Blanton HM, McAllister CK, Latham RD. Cardiac dysfunction in patients seropositive for the human immunodeficiency virus. West J Med 1991;155:373-379.
Kadima-Nzuji M, Craighead JE. T-lymphocyte effects on murine cytomegalovirus pulmonary infection. Am J Pathol 1990;137:907-912.
Kahn JO, Northfelt DW, Miles SA. AIDS-associated Kaposi's sarcoma. AIDS Clin Rev 1992;261-280.
Kanki PJ, Marlink R, Essex M, M'Boup S. Biology of HIV-2 infection in West Africa. In: Gene Regulation and AIDS, ed. Papas T, Portfolio Publishing Company of Texas, pp. 255-271, 1990.
Kaplan JE, Khabbaz RF, Murphy EL, Hermansen S, Roberts C, Lal R, Heneine W, Wright D, Matijas L, Thomson R, Rudolph D, Switzer WM, Kleinman S, Busch M, Schreiber GB and the Retrovirus Epidemiology Donor Study Group. Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:193-201.
Kaplan J, Sarnaik S, Lusher JM, Transfusion Safety Study Group. Increase in Leu2+Leu7+ lymphocytes in HIV-seropositive patients with hemophilia repeatedly treated with clotting factor concentrates. Clin Immunol Immunopath 1988;46:337-341.
Karasek MA. Origin of spindle-shaped cells in Kaposi sarcoma. Lymphology 1994;27:41-4.
Karlstrom AR, Levine RL. Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms. Proc Natl Acad Sci USA 1991;88:5552-6.
Karlstrom AR, Shames BD, Levine RL. Reactivity of cysteine residues in the protease from human immunodeficiency virus: identification of a surface-exposed region which affects enzyme function. Arch Biochem Biophys 1993;304:163-9.
Karve MM, Murali MR, Shah HM, Phelps DR. Rapid evolution of cardiac tamponade due to bacterial pericarditis in two patients with HIV-1 infection. Chest 1992;101:1461-1463.
Kaul S, Fishbein MC, Siegel RJ. Cardiac manifestations of acquired immune deficiency syndrome: A 1991 update. Am Heart J 1991;122:535-544.
Kennedy DJ, Lewis WP, Barnes PF. Yield of bronchoscopy for the diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Chest 1992;102:1040-1044.
Kilgore KS, Imlay MM, Szaflarski JP, Silverstein FS, Malani AN, Evans VM, Warren JS. Neutrophils and reactive oxygen intermediates mediate glucan-induced pulmonary granuloma formation through the local induction of monocyte chemoattractant protein-1. Lab Invest 1997;76:191-201.
Kim S, Byrn R, Groopman J, Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression. J Virol 1989;63:3708-3713.
Kim S, Ikeuchi K, Groopman J, Baltimore D. Factors affecting cellular tropism of HIV. J Virol 1990;64:5600-5604.
King MA, Neal DE, St. John R, Tsai J, Diaz PT. Bronchial dilation in patients with HIV infection: CT assessment and correlation with pulmonary function tests and findings at bronchoalveolar lavage. AJR Am J Roentgenol 1997;168:1535-1540.
Kitano K, Abboud CN, Ryan DH, Quan SG, Baldwin GC, Golde DW. Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood 1991;77:1699-1705.
Klasse J; Pipkorn R, Blomberg J, Han KH, Hilton B, Ferretti JA. Three-dimensional structure and antigenicity of transmembrane-protein peptides of the human immunodeficiency virus type 1. Effects of a neutralization-escape substitution. FEBS Lett 1993;323:68-72.
Kleinman S, Kaplan J, Khabbaz R, Calabro M, Thomson R, Busch M and the REDS Study Group. Evaluation of p21e-spiked Western blot (Immunoblot) in confirming human t-cell lymphotropic virus type I or II infection in volunteer blood donors. J Clin Microbiol 1994;32:603-7.
Kleinman SH, Niland JC, Azen SP, Operskalski EA, Barbosa LH, Chernoff AI, Edwards VM, Lenes BA, Marshall GJ, Nemo GJ, Norman GL, Perkins H, Pindyck J, Pitlick F, Rasheed S, Shriver K, Toy P, Tomasulo PA, Waldman A, Mosley JW, Transfusion Safety Study Group. Prevalence of antibodies to human immunodeficiency virus antibody type-1 among blood donors prior to screening: The Transfusion Safety Study/NHLBI Donor Repository. Transfusion 1989;29:572-580.
Konopka K, Davis BR, Larsen CE, Alford DR, Debs RJ, Duzgunes N. Liposomes modulate human immunodeficiency virus infectivity. J Gen Virology 1990;71:2899-2907.
Konopka K, Stamatatos L, Larsen CE, Bavis BR, Duzgunes N. Enhancement of human immunodeficiency virus type 1 infection by cationic liposomes: The role of CD4, serum and lipsome-cell interactions. J Gen Virology 1991;72:2685-2696.
Korber B, Okayama A, Donnelly R, Tachibana N, Essex M. PCR analysis of defective human T-cell leukemia virus type 1 (HTLV-1) proviral genomes in adult T cell leukemia. J Virol 1991;65:5471-5476.
Korelitz JJ, Busch MP, Kleinman SH, Williams AE, Zuck TF, Gilcher RO, Ownby HE, Co Chien H, Nemo GJ. Relationship between antibody to hepatitis B core antigen and retroviral infections in blood from volunteer donors. Transfusion 1996;36:232-237.
Korelitz JJ, Busch MP, Williams AE for the Retrovirus Epidemiology Donor Study. Antigen testing for human immunodeficiency virus (HIV) and the magnet effect: will the benefit of a new HIV test be offset by the numbers of higher-risk, test-seeking donors attracted to blood centers. Transfusion 1996;36:203-208.
Korelitz JJ, Williams AE, Busch MP, Zuck TF, Ownby HE, Matijas LJ, Wright DJ. Demographic characteristics and prevalence of serolocig markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study. Transfusion 1994;34:870-876.
Kornbluth RS, Munis JR, Oh PS, Meylan PR, Richman DD. Characterization of a macrophage-tropic HIV strain that does not alter macrophage cytokine production yet protects macrophages from superinfection by vesicular stomatitis virus. AIDS Res Hum Retroviruses 1990;8:1023-1026.
Koufopanou V, Burt A, Taylor JW. Concordance of gene genealogies reveals reproductive isolation in the pathogenic fungus Coccidioides immitis. Proc Natl Acad Sci USA 1997;94:5478-5482.
Koup RA, Pikora CA, Luzuriga KR, Brettler DB, Day ES, Mazzara GP, Sullivan JL. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: In vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med 1991;174:1593-1600.
Koup RA, Pikora CA, Mazzara G, Panicali D, Sullivan JL. Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection. Viral Immunology 1991;4:215-223.
Koup RA, Robinson JE, Nguyen QV, Pikora CA, Blais B, Roskey A, Panicali P, Sullivan JL. Antibody-dependent cell-mediated cytotoxicity directed by a human monoclonal antibody reactive with gp120 of HIV-1. AIDS 1991;5:1309-1314.
Koup RA, Sullivan JL, Levine PH, Brettler D, Mahr A, Mazzara G, McKenzie S, Panicali D. Detection of MHC class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 1989;73:1909-1914.
Koup RA, Sullivan JL, Levine PH, Brewster F, Mahr A, Mazzara G, McKenzie S, Panicali D. Antigenic specificity of antibody-dependent cellular cytotoxicity directed against human immunodeficiency virus in antibody-positive sera. J Virology 1989:63:584-590.
Kraus EM, Brettler DB, Forsberg AD, Sullivan JL. Pregnancy in a cohort of long-term partners of human immunodeficiency virus - seropositive hemophiliacs. Obst Gync 1991;78:735-738.
Kruskal BA, Satry K, Warner AB, Mathieu CE, Ezekowitz RAB. Phagocytic chimeric receptors require both transmembrane and cytoplasmic domains from the mannose receptor. J Exp Med 1992;176:1673-1680.
Kvale P. A decline in the pulmonary diffusing capacity does not indicate opportunistic lung disease in asymptomatic person infected with HIV. Am Rev Resp Dis 1993;148:390-395.
Kvale PA, Hansen NI, Markowitz N, Rosen MJ, Jordan MC, Meiselman L, Glassroth J, Reichman LB, Wallace JM, Stansell JD, Hopewell PC and the Pulmonary Complications of HIV Infection Study Group. Routine analysis of induced sputum is not an effective strategy for screening persons infected with human immunodeficiency virus for Mycobacterium tuberculosis or Pneumocystis carinii. Clin Infect Dis 1994;19:410-6.
Kwok S, Gallo D, Hanson C, McKinney N, Poiesz B, Sninsky JJ. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retrovir 1990;6:559-63.
Kwok S, Lipka J, McKinney N, Kellogg D, Poiesz B, Foung S, Sninksy JJ. Low incidence of HTLV infections in random blood donors with indeterminate Western blot patterns. Transfusion 1990;30:491-494.
Lammermeier DE, Sweeney MS, Haupt HE, Radovancevic B, Duncan JM, Frazier OH. Use of potentially infected donor hearts for cardiac transplantation. Ann Thorac Surg 1990;50:222-225.
Lang DJ, Kovacs AAS, Zaia JA, Doelkin G, Niland JC, Aledort L, Azen SP, Fletcher MA, Gauderman J, Gjerset GJ, Lusher J, Operskalski EA, Parker JW, Pegelow C, Vyas GN, Mosley JW, Transfusion Safety Study Group. Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. JAIDS 1989;2:540-549.
Lawrence JB, Marselle LM, Byron KS, Johnson CV, Sullivan JL, Singer RH. Subcellular localization of low-abundance human immunodeficiency virus nucleic acid sequences visualized by fluorescence in situ hybridization. Proc Natl Acad Sci USA 1990;87:5420-5424.
Lee SS, Hong SI, Lee DS, Kang YK, Kim CW, Jang JJ. Adult T-cell leukemia/lymphoma in a Korean -- a case report. J Korean Med Sci 1994;9:458-65.
Lee WR, Syu WJ, Du B, Matsuda M, Tan S, Wolf A, Essex M, Lee TH. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992;89:2213-2217.
Levine JD, Allan JD, Tessitore JH, Falcone N, Galasso F, Israel RJ, Groopman JE. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patient with AIDS/ARC. Blood 1991;78:3148-3154.
Levitz SM, North EA, Jiang Y, Nong SH, Kornfeld H, Harrison TS. Variables affecting production of monocyte chemotaactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans. Infect Immun 1997;65:903-908.
Levitz SM, Tabuni A, Wagner R, Kornfeld H, Smail EH. Binding of unopsonized Cryptococcus neoforms by human bronchoalveolar macrophages: Inhibition by a large-molecular-size serum component. J Infect Dis 1992;166:866-873.
Levy WS, Simon GL, Rios JC, Ross AM. Prevalence of cardiac abnormalities in human immunodeficiency virus infection. Am J Cardiol 1989;63:86-89.
Levy WS, Varghese PJ, Anderson DW, Leiboff RH, Orenstein JM, Virmani R, Bloom S. Myocarditis diagnosed by endomyocardial biopsy in human immunodeficiency virus infection with cardiac dysfunction. Am J Cardiol 1988;62:658-659.
Lewis W, Dorn GW. Cardiac structure and function in HIV-infected children. N Engl J Med 1993;328:513-514.
Lewis W, Gonzalez B, Chomyn A, Papoian T. Zidovudine induces molecular, bichemical, and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest 1992;89:1354-1360.
Lewis W, Lipsick J, Cammarosano C. Cryptococcal myocarditis in acquired immune deficiency syndrome. Am J Cardiol 1985;55:1240.
Lewis W, Papoian T. Molecular mechanisms of heart muscle disease. West J Med 1991;154:91.
Lewis W. AIDS. Cardiac findings from 115 autopsies. Prog Cardiovasc Dis 1989;32:207-215.
Li B, Rossman MD, Imir T, Oner-Eyuboglu AF, Lee CW, Biancaniello R, Carding SR. Disease-specific changes in gamma delta repertoire and function in patients with pulmonary tuberculosis. J Immunol 1996;157:4222-4229.
Li JJ, Poiesz BJ, Zaumetzer-Abbott L, Friedman-Kien AE. Detection of human immunodeficiency virus type 1 (HIV-1) in urine cell pellets from HIV-1 seropositive individuals. J Clin Microbiol 1992;30:1051-55.
Limper AH. Tumor necrosis factor alpha-mediated host defense against Pneumocystis carinii. Am J Respir Cell Mol Biol 1997;16:110-111.
Limper AH, Hoyte JS, Standing JE. The role of alveolar macrophages in Pneumocystis carinii degreadation and clearance from the lung. J Clin Invest 197;99:2110-2117.
Limper AH, Pottratx ST, Martin II WJ. Modulation of Pneumocystis carinii adherence to cultured lung cells by a mannose-dependent mechanism. J Lab Clin Med 1991;118:492-499.
Limper AH, Thoms CF, Anders RA, Leof EB. Interactions of parasite and host epithelial cell cycle during Pneumocystis carinii pneumonia. J Lab Clin Med 1997;130:132-138.
Linke MJ, Walzer PD. Identification and purification of a soluble species of gp120 released by zymolyase treatment of Pneumocystis carinii. J Protozool 1991;S38:176-178.
Lipka J, Bui K, Reyes G, Wiktor S, Blattner W, Murphy E, Hanson C, Sninsky J, Foung SKH. Determination of a unique and immunodominant epitope of HTLV-I. J Infect Dis 1990;162:353-357.
Lipka J, Santiago P, Chan L, Reyes G, Samuel KF, Blattner W, Shaw G, Hanson C, Sninsky J, Foung S. Modified Western blot assay for confirmation and differentiation of HTLV-I and HTLV-II infections. J Infect Dis 1991;164:400-403.
Lipka JJ, Miyoshi I, Hadlock KG, Reyes GR, Chow TP, Blattner WA, Shaw GM, Hanson CV, Gallo D, Chan L, Foung SKH. Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. J Infect Dis 1992;165:268-272.
Lipka JJ, Young KK, Kwok SY, Reyes GR, Sninsky JJ, Foung SK. Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals. Vox Sang 1991;61:171-176.
Lipshultz S, Easley K, Kaplan S, Starc T, Bricker JT, Lai W, Moodie D, Orav EJ, Colan S, and the P2C2 HIV Study Group. Cardiac dysfunction independently predicts mortality in HIV-infected children - The Prospective NHLBI P2C2 Study. Presented at the Third Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1995.
Loughran T, Coyle T, Sherman MP, Starkebaum G, Ehrlich GD, Ruscetti FW, Poiesz BJ. Detection of human T-cell leukemia/lymphoma virus, Type II, in a patient with large granular lymphocyte leukemia. Blood 1992;80:1116-9.
Loughran TP, Kidd P, Poiesz BJ. Familial occurrence of LGL leukemia. Br J Hemat 1994;87:199-201.
Loughran TP, Sherman MP, Ruscetti FW, Frey S, Coyle T, Montagna RA, Jones B, Starkebaum G, Poiesz BJ. Seroreactivity to HTLV-I/II proteins in patients with LGL leukemia. Leuk Res 1994;18:423-9.
Louie S, Cai J, Law R, Lin G, Lunardi-Iskandar Y, Jung B, Masood R, Gill. Effects of interleukin-1 and interleukin-1 receptor antagonist in AIDS-Kaposi's sarcoma. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:455-60.
Lovchik J, Lipscomb M, Lyons CR. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans. J Immunol 1997;158:1772-1778.
Lusher JM, Operskalski EA, Aledort LM, Dietrich SL, Gjerset GF, Hilgartner MW, Koerper MA, Pegelow CH, Lee H, Mosely JW, Transfusion Safety Study. Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disorders. Pediatrics 1991;88:242-249.
Luzuriaga K, Koup RA, Pikora CA, Brettler DB, Sullivan JL. Deficient HIV-1 specific cytotoxic T cell responses in vertically infected children. J Pediatric 1991:119:230-236.
Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, Viglianti GA. IL-16 represses HIV-1 promoter activity. J Immunol 1997;158:5-8.
Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St. Jeor SC. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 1992;80:170-178.
Maciejewski JP, Bruening EE, Donahue RE, Sellers SE, Carter C, Young NS, St. Jeor S. Infection of mononucleated phagocytes with human cytomegalovirus. Virology 1993;195:327-36.
Maciejewski JP, Weichold FF, Young NS. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-alpha. J Immunol 1994;153:4303-10.
Macon WR, Lo S-C, Poiesz BJ, Montefiori DC, Dawson MS, Mason TE, Michael PR, Cohen AG, Davis CM, Cousar JB, Stratton CW. Acquired immunodeficiency syndrome-like illness associated with systemic mycoplasma fermentans infection in a human immunodeficiency virus-negative homosexual man. Hum Pathol 1993;24:554-8.
Mallery SR, Lantry LE, Hegtvedt A, Lazo A, Titterington LC, Hout BL, Brierley GP, Stephens RE. Environmental induction of tumor phenotype in a putative Kaposi sarcoma progenitor cell. Lymphology 1994;27:45-8.
Mallery SR, Ng-Bautista CL, Lantry LE, Ness GM, Hegtvedt AK, Lazo A, Bailer RT, Hout BL, Stephens RE, Brierley GP. Cultured AIDS-related Kaposi's sarcoma cells retain a proliferative bioenergetic profile but demonstrate reduced cytoprotective capabilities. J Cell Biochem 1994;56:568-81.
Markowitz N. Tuberculin and energy testing in a cohort of HIV-seropositive and HIV seronegative individuals. Ann Intern Med 1993;119:185-193.
Masood R, Cai J, Law R, Gill P. AIDS-associated Kaposi's sarcoma pathogenesis, clinical features, and treatment. Curr Opin Oncol 1993;5:831-4.
Masood R, Husain SR, Rahman A, Gill P. Potentiation of cytotoxicity of Kaposi's sarcoma related to immunodeficiency syndrome (AIDS) by liposome-encapsulated doxorubicin. AIDS Res Hum Retroviruses 1993;9:741-746.
Masood R, Lunardi-Iskandar Y, Jean LF, Murphy JR, Waters C, Gallo RC, Gill P. Inhibition of AIDS-associated Kaposi sarcoma cell growth by DAB389-interleukin 6. AIDS Res Hum Retroviruses 1994;10:969-75.
Maytal J, Horowitz S, Lipper S, Poiesz B, Wang CY, Siegal FP. Progressive nemaline rod myopathy in a woman co-infected with HIV-1 and HTLV-2. Mt Sinai J Med 1993;60:242-6.
McClure E, Gaynor S, Veiga-Benach A, O'Neil D, Transfusion Safety Study Group. Counseling HIV infected recipients. Nursing 89--1989;10.
Mehta-Damani A, Markowicz S, Engleman EG. Generation of antigen-specific CD4+ T cell lines from naive precursors. Eur J Immunol 1995;25:1206-11.
Mehta-Damani A, Markowicz S, Engleman EG. Generation of antigen-specific CD8+ CTLs from naive precursors. J Immunol 1994;153:996-1003.
Mellonig JT, Prewett AB, Moyer MP. HIV inactivation in a bone allograft. J Periodontol 1992;63:979-983.
Merluzzi VJ, Hargrave KD, Labadia M, Grozinger K, Skoog M, Wu JC, Shih CK, Eckner K, Hattox S, Adams J, Rosehthal AS, Faanes R, Eckner RJ, Koup RA, Sullivan JL. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science 1990;250:1411-1413.
Meylan RP, Richman DD, Kornbluth RS. Characterization and growth in human macrophages of Mycobacterium avium complex isolated from the blood of patients with AIDS. Infect Immun 1990;58:2564-2568.
Miles SA, Balden E, Magpantay L, Wei L, Leiblein A, Hofheinz D, Toedter G, Stiehm ER, Bryson Y and the Souther California Pediatric AIDS Consortium. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Souther California Pediatric AIDS Consortium. N Engl J Med 1993;328:297-302.
Miles SA, Golde DW, Mitsuyasu RT. The use of hematopoietic hormones in HIV infection and AIDS-related malignancies. Hematol Oncol Clin North Am 1991;5:267-280.
Miles SA, Lee K, Hutlin L, Zsebo KM, Mitsuyasu RT. Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias. Blood 1991;78:3200-3208.
Miles SA, Martinez-Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, Radka SF, Linsley PS. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 1992;255:1432-1434.
Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreased hematologic toxicity from zidovudine. Blood 1991;77:2109-2117.
Miles SA, Wang H, Elashoff R, Mitsuyasu RT. Improved survival for patients with AIDS-related Kaposi's sarcoma. J Clin Oncol 1994;12:1910-6.
Miles SA. Hematopoietic growth factors as adjuncts to antiretroviral therapy. AIDS Res Hum Retroviruses 1992;8:1073-1080.
Miles SA. Kaposis sarcoma: a cytokine-responsive neoplasia? Cancer Treat Res 1992;63:129-140.
Miles SA. Pathogenesis of human immunodeficiency virus-related Kaposi's sarcoma. Curr Opin Oncol 1992;4:875-82.
Miles SA. The use of hematopoietic growth factors in HIV infection and AIDS-related malignancies. Cancer Invest 1991;9:229-38.
Miller K, Donegan E, Curran P, Shelley TJ, Transfusion Safety Study Group. Effects of counselling on knowledge about HIV-1 among transfusion recipients and their partners. AIDS Care 1990;2:155-162.
Mirri A, Rapezzi C, Iacopi F, Ortolani P, Binetti G, Fabbri M, Ortolani P, Zauli T, Pintori C, Baronie M, Cenacchi G, Re MC, Ferlini A, Chiodo F, Maresta A, Magnani B. Cardiac involvement in HIV infection: A prospective, multicenter clinical and echocardiographic study. Cardiologia 1990;35:203-209.
Mitsuyasu RT, Golde DW (eds). AIDS: The Hematology/Oncology Clinics of North America. Philadelphia, W.B. Saunders, 1991.
Mohagheghpour N, Chakrabarti R, Stein BS, Gowda SD, Engleman EG. Early activation events render T cells susceptible to HIV-1-induced syncytia formation: Role of protein kinase C. J Biol Chem 1991;266:7233-7238.
Molina JM, Ferriani R, Amirault C, Groopman JE. Purified recombinant CD4 inhibits HIV-1 infection of peripheral blood macrophages. Pathol Biol 1991;39:754-758.
Montagna RA, Papsidero L, Poiesz BJ. Evaluation of a solid phase immunoassay for the simultaneous detection of antibodies to human immunodeficiency virus type I and human T-cell lymphotropic virus type I. J Clin Micro 1991;29:897-900.
Morgan RA, Looney DJ, Muenchau DD, Wong-Staal F, Gallo RC, and Anderson WF. Retroviral vectors expressing soluble CD4: A potential gene therapy for AIDS. AIDS Research and Human Retroviruses 1990;6:183-191.
Morgan RA. Gene therapy for AIDS. The Genetic Resource 1990;10:47-49.
Morris PE, Glass J, Cross R, Cohen DA. Role of T-lymphocytes in the resolution of endotoxin-induced lung injury. Inflammation 1997;21:269-278.
Mosley JW, Nowicki M, Kleinman SH, Dietrich SL, Transfusion Safety Study Group. Reactivation of hepatitis B. Lancet 1989;1:1083-1084.
Mosley JW, Nowicki MJ, Kasper CK, Donegan E, Aledort LM, Hilgartner MW, Operskalski EA, Transfusion Safety Study Group. Hepatitis A virus transmission by blood products in the United States. Vox Sang 1994:67:S24-S28.
Moyer MP, Gendelman HE. HIV replication and persistence in human gastrointestinal cells cultured in vitro. J Leukoc Biol 1991;49:499-504.
Moyer MP, Ramirez A, Woolf A, Huot RI, McKee-Suarez MS. HIV infection of human gastrointestinal submucosal cells: an in vitro model that mimics Kaposi's sarcoma. In Vitro Cell Dev Biol 1991;27A:337-344.
Murphy E, Engstrom J, Miller K, Sacher R, Busch M, Hollingsworth C and the REDS Investigators. Case report - HTLV-II associated myelopathy in 43-year-old woman. Lancet 1993;341:757-8.
Narasimhan S, Armstrong MYK, Rhee K, Edman J, Phelps D, Richard FF, Spicer E. A laminin receptor-like protein from Pneumocystis carinii. In preparation.
Newman GW, Gan HX, McCarthy PL, Remold HG. Survival of human macrophages infected with Mycobacterium avium intracelulare correlatees with increased production of tumor necrosis factor -alpha and IL-6. J Immunol 1991;147:3942-3948.
Newman GW, Guarnaccia JR, Liu L, Remold HG. Human mononuclear cells infected with Mycobacterium avium intracellular (MAI) exhibit LFA-1/ICAM-1, CD-2/LFA-3 dependent aggregation. Abstracts of the symposium "Frontiers in Mycobacteriology: M. avium, the Modern Epidemic," Vail, CO, Oct. 15-19, 1992.
Nichols L, Florentine B, Lewis W, Sattler F, Rarick MU, Brynes RK. Bone marrow examination for the diagnosis of mycobacterial and fungal infections in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991;115:1125-1132.
Niland-Weiss J, Azen SP, Odom-Maryon T, Lui F, Hagerty C, Transfusion Safety Study Group. A microcomputer-based distributed data management system for a large cooperative study of transfusion-associated acquired immunodeficiency syndrome. Comput Biomed Res 1987;20:225-243.
Nong Y, Kandil O, Tobin EH, Rose RM, Remold HG. The HIV core protein p24 inhibits interferon-ç induced-increase of HLA-DR and cytochrome b heavy-chain mRNA levels in the human monocyte-like cell line THP1. Cell Immunol 1991;132:10-16.
Norman GL, Barker SS, Rasheed S, Transfusion Safety Study Group. Immunoblot reactivity of a non-HIV protein with human sera. J Clin Lab Anal 1909;3:148-151.
Nowicki MJ, Mosley JW, Koerper MA, Aledort LM, Lusher JM, Hilgartner MW. Passive antibody to hepatitis A virus in U.S. haemophilics. Lancet 1993;341:562.
Nussbaum JM, Dealist C, Lewis W, Heseltine PN. Rapid diagnosis by buffy coat smear of disseminated mycobacterium avium complex infection in patients with acquired immunodeficiency syndrome. J Clin Microbiol 1990;28:631-632.
Odom-Maryon T, Langholz B, Niland J, Azen S, Transfusion Safety Study Group. Generalization of normal discriminant analysis using Fourier series density estimators. Stat Med 1991;10:473-485.
Odrlfin TM, Francis CW, Sporn LA, Bunce LA, Marder VJ, Simpson-Haidaris PJ. Heparin-binding domain of fibrin mediates its binding to endothelial cells. Arterioscler Thromb Vasc Biol 1996;16:1544-1551.
Odrljin TM, Shainoff JR, Lawrence SO, Simpson-Haidaris PJ. Thrombincleavage enhances exposure of a heparin binding domain in the N-terminus of the fibrin beta chain. Blood 1996;88:2050-2061.
Oh SK, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J, Kornfeld H. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. JAIDS 1992;5:251-256.
Okayama A, Chen YA, Tachibana N, Shioiri S, Lee TH, Tsuda K, Essex M. High incidence of antibodies to HTLV-I TAX in blood relatives of adult T-cell leukemia patients. J Infect Dis 1991;163:47-52.
Okayama A, Korber B, Chen YM, Allan J, Lee TH, Shioiri S, Tachibana N, Tsuda K, Mueller N, McLane M, Mayan S, Marlink R, Orgad S, Essex M. Unusual pattern of antibodies to human T-cell leukemia virus type-I in family members of adult T-cell leukemia patients. Blood 1991;78:3323-3329.
Operskalski EA, Schiff ER, Kleinman SH, Busch MP, Taylor PE, Parks WP, Lee HH, Tomasulo PA, Donegan E, Stuart M, Hollingsworth CG, Nemo GJ,Mosley JW, and the Transfusion Safety Study Group. Epidemiologic background of blood donors with antibody to human T-cell lymphotropic virus. Transfusion 1989;29:746-748.
Operskalski EA, Stram DO, Lee H, Donegan E, Busch MP, Stevens CE, Schiff ER, Dietrich SL, Mosley JW, Transfusion Safety Study Group. Human immunodeficiency virus type 1 infection: Relationship of risk group ad age to rate of progression to AIDS. J Infect Dis 1995;172:648-55.
Ownby HE, Korelitz JJ, Busch MP, Williams AE, Kleinman SH, Gilcher RO, Nourjah P, and the Retrovirus Epidemiology Donor Study. Loss of volunteer blood donors because of unconfirmed enzyme immunoassay screening results. Transfusion 1997;37:199-205.
P2C2 Study Group. The pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus (P2C2 HIV) infection study: Design and methods. J Clin Epidemiol 1996;49:1285-94.
Pacht ER, Diaz P, Clanton T, Hart J, Gadek JE. Alveolar fluid glutathione decreases in asymptomatic HIV-seropositive subjects over time. Chest 1997;112:785-788.
Palange P, Carlone S, Venditti M, Antony VB, Angelici E, Forte S, Sorice F, Serra P. Alveolar cell population in HIV-infected patients. Eur J Respir Dis 1991;4:639-642.
Papsidero L, Swartzwelder F, Sheu M, Montagna R, Ehrlich G, Sninsky J, Dosik H, Bhagavati S, Poiesz B. Immunodetection of human T-cell lymphotropic virus type I core protein in biological samples using a monoclonal antibody immunoassay. J Clin Microbiol 1990;28:949-55.
Papsidero LD, Dittmer RP, Vaickus L, Poiesz B. Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of Human T-Cell Lymphotropic Virus. J Clin Microbiol 1992;30:351-358.
Paraf F, Py A, Pauly-Laubry C, Camilleri JP. Cardiac pathology in human immunodeficiency virus infection. Arch Anat Cytol Pathol 1990;38:171-179.
Parker JW, Adelsberg B, Azen SP, Boone D, Fletcher MA, Gjerset GF, Hassett J, Kaplan J, Niland JC, Odom-Maryon T, Operskalski EA, Prince H, Scott D, Stites DP, Mosley JW, Transfusion Safety Study Group. Leukocyte immunophenotyping by flow cytometry in a multisite study: Standardization quality control, and normal values in the Transfusion Safety Study. Clin Immunol Immunpathol 1990;55:187-220.
Park DR, Skerrett SJ. IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma: differential responses of blood monocytes and alveolar macrophages. J Immunol 1996;157:2528-2538.
Parks WP, Lenes BA, Tomasulo PA, Schiff ER, Parks ES, Shaw GM, Lee HH, Yan H-Q, Lai S, Hollingsworth CG, Nemo GJ, Mosley JW, and the Transfusion Safety Study Group. Human T-cell lymphotropic virus infection among blood donors in South Florida. JAIDS 1991;4:89-96.
Pasula R, Downing JF, Wright JR, Kachel DL, Davis TE, Martin WJ. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am J Respir Cell Mol Biol 1997;17:209-217.
Paulsrud JR, Queener SF, Bartlett MS, Smith JW. Isolation and characterization of rat lung Pneumocystis carinii gp120. J Protozool 1991;38:10S-11S.
Pearce TE, Nowakowski M, Eden E, Huang ZB, Steiner P, Shahabuddin M, Potash MJ, Volsky. Uniform detection of HIV-1 in alveolar macrophages of pediatric but not adult AIDS patients. J Leucoc Biol 1993;53:722-726.
Perez RL, Roman J. Fibrin enhances the expression of IL-1 beta by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J Immunol 1995;154:1879-1887.
Perkins HA, Cordell R, Bueno C, Shiota J, Hitchcock B. Progressive decrease in proportion of blood donors with antibody to HIV. Transfusion 1987;27:502.
Perl A, Gorevic P, Condemi J, Papsidero L, Poiesz B, Abraham G. Antibodies to retroviral proteins and reverse transcriptase activity in patient with essential cryoglobulinemia. Arth Rheumat 1991;34:1313-8.
Perl A, Rosenblatt J, Chen ISY, DiVincenzo J, Bever R, Poiesz B, Abraham G. Detection and cloning of new HTLV-related endogenous sequences in man. Nucleic Acid Res 1989;17:6841-54.
Perno CF, Crowe SM, Kornbluth RS. A continuing enigma: the role of cells of macrophage lineage in the development of HIV disease. J Leukoc Biol 1997;62:1-3.
Perry DG, Wisniowski P, Daugherty GL, Downing J, Martin WJ. Nonimmune phagocytosis of liposomes by rat alveolarmacrophages is enhanced by vitronectin and is vitronectin-receptor mediated. Am J Respir Cell Mol Biol 1997;17:462-470.
Poiesz B, Sherman M, Saksena N, Dube D, Dube S, Gavalchin J, Fan N, Lane M, Paul B. The biology and epidemiology of the human T-cell lymphomia leukemia viruses. In Frontiers of Infectious Diseases. Focus on HIV, Ed. HC Neu, J Levy, R Weiss, Churchhill Livingstone, London, England, 1993;189-205.
Poiesz B, Sherman M, Saksena N, Dube D, Paul B, Erensoy S, Dube S, Fan N, Gavalchin J, Lane M. The biology and epidemiology of the primate T-cell lymphoma/leukemia viruses. J Prevent Med Hyg 1992;32:S7-S8.
Poiesz BJ, Abbott L, Bryz-Gornia L, Jones B, Rubert M, Stephens C. Detection of human retroviral infection. J Prevent Med Hyg 1992;32:S29-S30.
Poiesz BJ, Byrne BC. Retroviruses and Antiretroviral therapy. In Clinical Practice of Gynecology: AIDS Issue, Elsevier Science Publishing Co., 1989; 81-107.
Poiesz BJ, Ehrlich GD, Byrne BC, Wells K, Kwok S, Sninsky J. Use of polymerase chain reaction in the detection, quantification, and characterization of human retroviruses. In Current Communications in Molecular Biology, Polymerase Chain Reaction, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, 159-164.
Poiesz BJ, Ehrlich GD, Byrne BC, Wells K, Kwok Sh, Sninksy J. The use of the polymerase chain reaction in the detection, quantification and characterization of human retroviruses. Medical Virology 1990;9:47-75.
Poiesz BJ, Williams WJ. T4 lymphomas involving the skin. In Hematology, 4th Edition, edited by WJ Williams, E. Beutler, AJ Ersely and MA Lichtman, McGraw-Hill Book Co., New York, 1990, 1089-1100.
Poiesz BJ. Molecular epidemiology and biology of HTLV-I Infection in The United States - Japan Cooperative Cancer Research Program: Progress Report, April 1992-March 1993. Ed. H Osaki, T Kakefuda, The National Cancer Institute and Japan Society for the Promotion of Science 1994;143-4.
Pollack AL, Barth AIM, Altschuler Y, Nelson WJ, Mostov KE. Dynamics of beta-catenin interactions with APC protein regulate epithelial tubulogenesis. J Cell Biol 1997;137:1651-1662.
Pomerantz RJ, Feinberg MG, Andino R, Baltimore D. The long terminal repeat is not a major determinant of the cellular tropism of human immunodeficiency virus type 1. J Virol 1991;65:1041-1045.
Pomerantz RJ, Trono D, Feinberg MB, Baltimore D. Cells nonprotectively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency. Cell 1990;61:1271-1276.
Potash MJ, Li G, Shahabuddin M, Pellegrino MG, Volsky DJ. Human immunodeficiency virus type 1 infection requires reverse transcription of nascent viral RNA. DNA Cell Biol 1993;12:685-693.
Potash MJ, Zeira M, Huang ZB, Pearce TE, Eden E, Gendelman HE, Volsky DJ. Virus-cell membrane fusion does not predict efficient infection of alveolar macrophages by human immunodeficiency virus type 1 (HIV-1). Virology 1992;188:864-868.
Pottratz ST. Evidence of Pneumocystis carinii binding to a cell-free substrate: role of the adhesive protein fibronectin. J Lab Clin Med 1994;123:273-281.
Pottratz ST, Paulsrud P, Smith JP, Martin II WJ. Pneumocystis carinii attachment to cultured lung cells by Pneumocystis gp120, a fibronectin binding protein. J Clin Invest 1991;88:403-407.
Pottratz ST, Weir AL. Gamma-interferon inhibits Pneumocystis carinii attachment to lung cells by decreasing expression of lung cell-surface integrins. Eur J Clin Invest 1997;27:17-22.
Pulmonary Complications of HIV Infection Study Group. Design of a prospective study of the pulmonary complications of HIV infection. 1993;46:497-507.
Raines MA, Golde DW, Dasipour M, Nel AE. Granulocyte-macrophage colony-stimulating factor activates microtubule-associated protein 2 kinase in neutrophils via a tyrosine kinase-dependent pathway. Blood 1992;79:3350-3354.
Raines MA, Liu L, Quan SC, Joe V, DiPersio JF, Golde DW. Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor. Proc Natl Acad Sci USA 1991;88:8203-8207.
Rao AV, Katzin J, Mossar M, Huitsing J, Glassroth J. Operational problems of external review. App Clin Trials 1993;2:34-42
Rapezzi C, Binetti G, Iacobitti P, Mirri A, Ortolani P, Magnani B. Cardiac involvement in HIV infection. Cardiologia 1989;34:823-827.
Rarick MU, Loureiro C, Groshen S, Sullivan-Halley J, Gill PS, Bernstein-Singer M, Levine AM. Serum erythropoietin titers in patients with human immunodeficiency virus (HIV) infection and anemia. J Acquir Immune Defic Syndr 1991;4:593-597.
Rarick MU, Montgomery T, Groshen S, Sullivan-Halley J, Jamin D, Mazumder A, Gill PS, Loureiro C, Levine AM. Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia. Am J Hematol 1991;38:261-266.
Rawal B, Vyas GN, Yen TSB, Endow R, Heitman J, Busch MP. Leukocyte filtration removes HIV-infected lymphocytes and infectious particulate cell debris but not free virus. Vox Sang 1991;60:214-218.
Rawal BD, Bartolini F, Vyas GN. In vitro inactivation of human immunodeficiency virus by ascorbic acid. Biologicals 1995;23:75-81.
Rawal BD, Schwadron R, Busch MP, Endow R, Vyas GN. Evaluation of leukocyte removal filters modelled by use of HIV-infected cells and DNA amplification. Blood 1990;76:2159-2161.
Reardon CC, Kim SJ, Wagner RP, Kornfeld H. Interferon-gamma reduces the capacity of human alveolar macrophages to inhibit growth of Cryptococcus neoformans in vitro. Am J Respir Cell Mol Biol 1996;15:711-715.
Ribes JA, Limper AH, Espy MJ, Smith TF. PCR detection of Pneumocystis carinii in bronchoalveolar lavage specimens: analysis of sensitivity and specificity. J Clin Microbiol 1997;35:830-835.
Rice WR, Burton FM, Fiedeldey DT. Cloning and expression of the alveolar type II cel P2u-purinergic receptor. Am J Respir Cell Mol Biol 1995;12:27-32.
Rodriguez ER, Nasim S, Hsia J, Sandin RL, Ferreira A, Hilliard BA, Ross AM, Garrett CT. Cardiac myocytes and dendritic cells harbor human immunodeficiency virus in infected patients with and without cardiac dysfunction: Detection by multiplex, nested, polymerase chain reaction in individually microdissected cells from right ventricular endomyocardial biopsy tissue. Am J Cardiol 1991;68:1511-1520.
Romieu I, Marlink R, Kanki P, M'Boup S, Essex M. HIV-2 link to AIDS in West Africa. J AIDS 1990;3:220-230.
Rose RM, Catalano P, Koziel H, Furlong ST. Abnormal lipid composition of bronchoalveolar lavage fluid obtained from individuals with AIDS-related lung disease. Am J Respir Crit Care Med 1994;149(2 Pt 1):332-8.
Rose RM, Krivine A, Pinkston P, Gillis JM, Huang A, Hammer SM. Frequent identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with acquired immunodeficiency syndrome. Am Rev Respir Dis 1991;143:850-854.
Rosenblum L, Darrow W, Witte J, Cohen J, French J, Gill PS, Potterat J, Sikes K, Reich R, Hadler S. Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. JAMA 1992;267:2477-2481.
Rossman MD, Carding SR. Gamma delta T cells in asthma. Ann Intern Med 1996;124:266-7.
Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, Hiebert C, Hess P, Joyce L, Bergsland J, Gazzaniga A. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 1989;97:194-203.
Russell DG, Sturgill-Koszycki S, Vanheyningen T, Collins H, Schaible UE. Why intracellular parasitism need not be a degreading experience for Mycobacterium. Philos Trans R Soc Lond B Biol Sci 1997;352:1301-1310.
Sakaguchi M, Sato T, Groopman JE. Human immunodeficiency virus infection of megakaryocytic cells. Transfusion 1991;77:481-485.
Sakaguchi M, Zenzie-Gregory B, Groopman JE, Smale ST, Kim S. An alternative pathway for induction of human immunodeficiency virus gene expression: Involvement of the general transcription machinery. J Virol 1991;65:5448-5456.
Saksena N, Herve V, Durand JP, LeGuenno B, Diop O, Dugoutte JP, Mathiot C, Muller M, Love J, Dube S, Sherman M, Benz P, Erensoy S, Galat-Loung A, Galat G, Paul B, Dube D, Barre-Sinoussi F, Poiesz B. Seroepidemiologic, molecular and phylogenetic analyses of Simian T-cell leukemia viruses (STLV-I) from various naturally infected monkey species from Central and Western Africa. Virology 1994;198:297-310.
Saksena NK, Herve V, Sherman MP, Durand J, Paul M, Muller C, Love JL, Sinoussi FB, Dube DK, Poiesz BJ. Sequence and phylogenetic analyses of a new STLV-1 from a naturally infected tantalus monkey from Central Africa. Virology 1993;192:312-20.
Saksena NK, Sherman MP, Yanagihara R, Dube D, Poiesz BJ. LTR sequence and phylogenetic analysis of a newly discovered variant to HTLV-isolated from the Hagahai of Papau New Guinea. Virology, 1992;189:1-9.
Samson M, Libert F, Doranz BJ, Rucker J, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-5.
Saukkonen JJ, Kornfeld H, Berman JS. Expansion of a CD8=CD28- cell population in blood lung of HIV-positive patients. JAIDS 1993;6:1194-1204.
Sawyers CL, Giehizky ML, Quan S, Golde DW, Witte ON. Propagation of human blastic myeloid leukemia in the SCID mouse. Blood 1992;79;2089-2098.
Scadden DT, Wang Z, Groopman JE. Quantitation of plasma human immunodeficiency viurs type 1 RNA by competitive polymerase chain reaction. J Infec Dis 1992;165:1119-1123.
Scadden DT, Zeira M, Woon A, Wang Z, Schieve L, Ikeuchi K, Lim B, Groopman JE. Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990;76:317-322.
Schecter A, Poiesz BJ, Brandt-Rauf P, Papke O, Ball M. Dioxin levels in blood of AIDS patients and controls. Med Sci Res 1991;19:273-5.
Schinazi RF, Chu CK, Eriksson BF, Sommadossi JP, Doshi KJ, Oswald B, McClure HM. Antiretroviral activity, biochemistry, and pharmacokinetics of 3'-azido-2',3'-dideoxy-5-methylcytidine. Ann NY Acad Sci 1991;616:385-397.
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ for the Retrovirus Epidemiology Donor Study. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-1690.
Scofield VL, Poiesz B, Diagne A, Kennedy C, Broder S, Rao B. HIV binds to normal sperm and is present at DNA in sperm from infected men. AIDS 1994;8:12.
Sekigawa I, Groopman JE, Allan JD, Ikeuchi K, Biberfeld G, Takatsuki K, Byrn RA. Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Clin Immunol Immunopathol 1991;58:145-153.
Shaw DR, Knight DR, Waterman AL, Sommadossi JP. 3'-azido-3'-deoxyuridine inhibition of human lymphocyte cytolytic function in vitro. Biochem Pharmacol 1991;41:287-292.
Shepherd VL, Lane KB, Abdolrasulnia R. Ingestion of Candida albicans down-regulates mannose receptor expression on rat macrophages. Arch Biochem Biophys 1997;344:350-356.
Sherman M, Poiesz B. Cytokines and human retroviruses. In Clinical Application of Cytokines: Role in Pathogenesis, Diagnosis and Therapy. Ed. JJ Rossio, JL and AJH Gearing. Oxford Press, New York, NY 1993;93-103.
Sherman M, Poiesz. Insights into HTLV-I structure, function, and evolution. Kaleidoscope, ed. S. Rassu, 1992, 1-51.
Sherman MP, Amin RM, Rodgers-Johnson PEB, Morgan OSC, Char G, Iannone R, Collins GH, Papsidero L, Gibbs LJ, Poiesz BJ. Identification of human T-cell lymphoma/leukemia virus type I antibodies, DNA and protein in polymyositis/dermatomyositis patients. Arthri Rheum 1995;38:690-8.
Sherman MP, Dock NL, Ehrlich GD, Sninsky JJ, Brothers C, Gillsdorf J, Bryz-Gornia V, Poiesz BJ. Evaluation of HIV-I Western blot indeterminate blood donors for the presence of human or bovine retroviruses. AIDS Res Hum Retrovir 1995;11:409-14.
Sherman MP, Dube D, Saksena NK, Poiesz BJ. Non-AIDS human retrovirus infection. Update, Canadian Pediatric Society, 1991, 20.
Sherman MP, Dube DK, Saksena NK, Poiesz BJ. Human T-cell lymphoma/leukemia retroviruses and malignancy. In Leukemia: Advances in Research and Treatment, eds. EJ Freireich, H Kantarjian, Kluwer Academic Publishers 1993;79-103.
Sherman MP, Dube S, Spicer TP, Kane TD, Love JL, Saksena NK, Iannone R, Gibbs CJ, Yanagihara R, Dube DK, Poiesz BJ. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I (HTLV-I), gp46, extracellular membrane protein from a patient with both HTLV-I associated myelopathy and adult T-cell leukemia. Cancer Res 1993;53:6067-73.
Sherman MP, Ehrlich GD, Ferrer JF, Sninsky JJ, Zandomeni R, Dock NL, Poiesz BJ. Amplification and analysis of specific DNA and RNA sequences of the bovine leukemia virus from infected cows by the polymerase chain reaction. J Clin Microbiol 1992;30:185-91.
Sherman MP, Saksena NK, Dube DK, Yanagihara R, Poiesz BJ. Evolutionary insights on the origin of human T-cell lymphoma/leukemia virus type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea. J Virol 1992;66:2556-63.
Shermata Wa, Harrington WJ, Bradshaw PA, Foung SKH, Berger JR, Resnick L, Poiesz BJ. Association of "(Tropical) ataxic neuropathy" with HTLV-II. Virol Res 1993;29:71-77.
Schulz L, Nagaraja HN, Rague N, Drake J, Diaz PT. Respiratory muscle dysfunction associated with human immunodeficiency virus infection. Am J Resppir Crit Care Med 1997;155:1080-1084.
Schwander SK, Sada E, Torres M, Escobedo D, Sierra JG, Alt S, Rich EA. T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J Infect Dis 1996;173:1267-1272.
Siddiqi AM, Jennings VM, Kidd MR, Actor JK, Hunter RL. Evaluation of electrochemiluminescence- and bioluminescence-based assays for quantitating specific DNA. J Clin Lab Anal 1996;10:423-431.
Simm M, Chao W, Pekarskaya O, Sova P, Gupta P, Balachandran R, Volsky DJ. Genetic variability and function of the long terminal repeat from syncytium-inducing and non-syncytium-inducing human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1996;12:801-809.
Simm M, Shahabuddin M, Chao W, Allan JS, Volsky DJ. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J Virol 1995;69:4582-4586.
Singer RH, Byron KS, Lawrence JB, Sullivan JL. Detection of HIV-1 infected cells from patients using non-isotopic in situ hybridization. Blood 1989;74:2295-2301.
Smulian AG, Stringer JR, Linke JJ, Walzer PD. Isolation and characterization of a recombinant immunoreactive antigen of pneumocystis carinii. 1992;60:907-915.
Smulian AG, Stringer JR, Linke MJ, Walzer PD. Expression cloning of Pneumocystis carinii antigens. J Protozool 1991;S38:8-10.
Sommadossi JP, Shu Z, Carlisle R, Xie MY, Weidener DA. Pharmacologic studies of nucleosiese active against the human immunodeficiency virus. Ann NY Acad Sci 1991;616:356-366.
Sova P, van Ranst M, Gupta P, Balachandran R, Chao W, Itescu S, McKinley G, Volsky DJ. Conversation of an intact human immunodeficiency type 1 vif gene in vitro and in vivo. J Virol 1995;69:2557-64.
Steffen HM, Schrappe-Bacher M, Muller R, Salzberger MB, Fatkenheuer G, Geisler S, Degenhardt S, Griebenow R. Cardiac involvement within the scope of HIV-1 infection: Preliminary results of echocardiography study. Z Kardiol 1990;79:83-88.
Stein BS, Engleman EG. Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J Biol Chem 1990;265:2640-2649.
Stein BS, Engleman EG. Intracellular processing of the gp160 HIV-1 envelope precursor. J Biol Chem 1990;265:2640-9.
Stetler-Stevenson WG, Bersch N, Golde DW. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Letters 1992;296:231-234.
Stevenson M. Pathway to understanding AIDS. Nat Struct Biol 1996;3:303-304. Steward JM, Kaul A, Gromisch DS, Reyes E, Woolf PK, Gowitz MH. Symptomatic cardiac dysfunction in children with human immunodeficiency virus infection. Am Heart J 1989;117:140-144.
Strieter RM, Kock AE, Antony VB, Fick RB, Standiford TJ, Kunkel SL. The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant-protein-1. J Lab Clin Med 1994;123:183-197.
Sturgill-Koszycki S, Schaible UE, Russell DG. Mycobacterium-containing phagosomes are accessible to early endosomes and reflect a transitional state in normal phagosome biogenesis. EMBO J 1996;15:6960-6968.
Su T. Pathogenesis and host response in Pneumocystis carinii pneumonia. Ann Rev Med 1994;45:261-272.
Sullivan JL, Koup RA. Why high levels of virus-specific CTL persist in HIV-1-infected individuals. In: HIV-Specific Cytotoxic T Lymphocytes, 24th Forum in Immunology. Organized by F Plata. Res Immunol 1989;140:89-124.
Sullivan MT, Williams AE, Chyang TF, Grandinetti T, Poiesz BJ, Ehrlich GD, and the American Red Cross HTLV-I/II Collaborative Study Group. Transmission of Human t-Lymphotropic Virus Types I and II by blood transfusion. A retrospective study of recipients of blood components (1983-1988). Arch Int Med 1991;151:2043-8.
Sullivan MT, Williams AE, Fang CT, Notari EP, Poiesz BJ, Ehrlich GD and the American Red Cross HTLV-I/II Collaborative Study Group. HTLV-I and HTLV-II infection in sexual contacts and family members of seropositive blood donors. Transfusion 1993;33:585-90.
Sumner SC, Gallagher KS, Davis DG, Covell DG, Jernigan RL, Ferretti JA. Conformational analysis of the tachykinins in solution: substance P and physalaemin. J Biomol Struct Dyn 1990;8:687-707.
Sumner SC, Jiang SP, Jernigan RL, Ferretti JA. Conformational analysis of receptor selective tachykinin analogs: senktide and septide. J Biomol Struct Dyn 1992;10:429-39.
Sunzeri FJ, Lee T-H, Brownlee RG, Busch MP. Rapid simultaneous detection of multiple retroviral DNA sequences using the polymerase chain reaction and capillary DNA chromatography. Blood 1991;77:879-886.
Syu WJ, Lee WR, Du B, Yu QC, Essex M, Lee TH. Role of conserved gp41 cysteine residues in the processing of human immunodeficiency virus envelope precursor and viral infectivity. J Virol 1991;65:6349-6352.
Theodore AC, Kornfeld H, Wallace RP, Cruikshank WW. CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. J Acquir Immune Defic Syndr 1994;7:899-907.
Thomas CF, Gustafson M, Vuk-Pavlovic Z, Leof EB, Limper AH. Identification of a cell division cycle (cdc2) homologue in Pneumocystis carinii. J Eukaryot Microbiol 1996;43:11S
Toossi Z, Hirsch CS, Hamilton BD, Knuth CK, Friedlander MA, Rich EA. Decreased production of TGF-beta 1 by human alveolar macrophages compared with blood monocytes. J Immunol 1996;156:3461-3468.
Toossi Z, Nicolacakis K, Xia L, Ferrari NA, Rich EA. Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:325-331.
Toossi Z, Sierra-Madero JG, Blinkhorn RA, Mettler MA, Rich EA. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med 1993;177:1511-6.
Tosco A, Gargano S, Kobayashi GS, Maresca B. An AP1 element is involved in transcriptional regualtion of delta9-desaturase gene of Histoplasma capsulatum. Biochem Biophys Res Commun 1997;230:457-461.
Trono D, Baltimore D. A human cell factor is essential for HIV-1 Rev action. EMBO 1990;9:4155-4160.
Turco M, Seneff M, McGrath BJ, Hsia J. Cardiac Tamponade in the acquired immunodeficiency syndrome. Am Heart J 1990;120:1467-1468.
Turnicky RP, Goodin J, Smialek JE, Herskowitz A, Beschorner WE. Incidental myocarditis with intravenous drug abuse: the pathology, immunopathology, and potential implications for human immunodeficiency virus-associated myocarditis. Hum Pathol 1992;23:138-143.
Twigg R. Immunology and non-immunology lung defense mechanisms. In Allergy Principles and Practices, CV Mosby, St. Louis, MO, 1993, 428-446.
Twigg HL, Spain BA, Soliman DM, Bowen LK, Heidler KM, Wilkes DS. Impaired IgG Production in the Lungs of HIV-infected individuals. Cellular Immunology 1996;170:127-133.
Ulrich PP, Busch MP, El-Beik T, Shiota J, Vennari J, Shriver K, Vyas GN. Assessment of human immunodeficiency virus expression in cocultures of peripheral blood mononuclear cells from healthy seropositive subjects. J Med Virol 1988;25:1-10.
Ulrich PP, Vyas GN. Infectious complications of blood transfusions. J Intens Care Med 1992;7:67-83.
VanHeyningen TK, Collins HL, Russell DG. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses. J Immunol 1997;158:330-337.
Viscidi RP, Hill PM, Li S, Cerny E, Vlahov D, Farzadegan H, Halsey N, Kelen GD, Quinn TC. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides. JAIDS 1991;4:1190-1198.
Vyas GN, Yang G, Murphy E. Transfusion-related transmissible diseases: detection by polymerase chain reaction-amplified genes of the microbial agents. Trans Med Rev 1994;8:253-266.
Vyas GN. Transfusion-acquired infections. In: Immunologic Effects of Blood Transfusion, ed. DP Singhal, CRC Press, 1995;1-17.
Wagner RP, Levits SM, Tabuni A, Kornfeld H. HIV-1 envelope protein (gp120) inhibits the activity of human bronchoalveolar macrophages against cryptococcus neoformans. Am Rev Respir Dis 1992;146:1434-1438.
Wallace J. Respiratory illnesses in persons with HIV infection. Am Rev Resp Dis 1993;148:1523-1529.
Wallace JM, Rao AV, Glassroth J, et al. Respiratory illness in persons with human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group. Am Rev Respir Dis 1993;148(6 Pt 1):1523-9.
Walzer PD, Foy J, Steel PE, Kim CK, White M, Kline R, Otter B, Allegra C. Activities of antifolate, antiviral, and other drugs in an immunosuppressed rat model of Pneumocystis carinii pneumonia. Antimicrob Agents Chemother 1992;36:1935-1942.
Walzer PD, Foy J, Steel PE, White M. Treatment of experimental pneumocystosis: Review of 7 years of experience and development of a new system for classifying antimicrobial drugs. Antimicrob Agents Chemother 1992;36:1943-1950.
Walzer PD. Overview of animal models of Pneumocystic carinii pneumonia. J Protozool 1991;38:122S-123S.
Ward BE, Myers F, Welch JC, Silverman P, Moyer MP, Wright L. HIV seroprevalence survey. Del Med J 1991;63:19-26.
Way DL, Witte MH, Fiala M, Ramirez G, Nagle RB, Bernas MJ, Dictor M, Borgs P, Witte CL. Endothelial transdifferentiated phenotype and cell-cycle kinetics of AIDS-associated Kaposi sarcoma cells. Lymphology 1993;26:79-89.
Weaver T, Hall CL, Kachel DL, Ward RP, Williams MD, Perry DG, Wisiowski P, Martin WJ. Assessment of in vivo attachement/phagocytosis by alveolar macrophages. J Immunol Methods 1996;193:149-156.
Weich HA, Salahuddin SZ, Gill P, Nakamura S, Gallo RC, Folkmann J. Aids-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin. Am J Pathol 1991;139:1251-1258.
Weikert LF, Edwards K, Chroneos ZC, Hager C, Hoffman L, Shepherd VL. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor. Am J Physiol 1997;272(5 Pt. 1):989-995.
Weintrub PS, Ulrich PP, Edwards JR, Boucher FB, Cowan MJ, Vyas GN. Use of polymerase chain reaction for the early detection of HIV infection in the infants of high-risk women. AIDS 1991;5:881-884.
Wells KH, Byrne BC, Poiesz BJ. Detection prevention and treatment of retroviral infections. Semin Oncol 1990;17:295-320.
Wells KH, Latino J, Gavalchin J, Poiesz BJ. Inactivation of Human Immunodeficiency Virus Type 1 by ozone in vitro. Blood 1991;78:1882-90.
Wells KH, Poiesz BJ. Biology and epidemiology of human retroviruses. J Amer Acad Derm 1990;22:1175-95.
Wells KH, Poiesz BJ. Biology of retroviruses: Detection molecular biology, and treatment of retroviral infection. Ob Gyn Clin N Am 1991;17:489-521.
Whitley RJ, Connell J, Markiewicz MA, Sommadossi MP. Novel pharmacologic strategies in the treatment of life-threatening cytomegalovirus infection: Clinical experience with continuous infusion 9(1,3-dihydroxy-2-propoxymethyl) guamine. Ann NY Acad Sci 1991;116:452-460.
Willoughby SB, Vlahov D, Herskowitz A. Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users. Am J Cardiol 1993;71:446-447.
Winters WL, McIntosh HD, Cheitlin MD, Elon R, Graboys TB, King SP, Murdaugh C, Orentlicher D, Ports TA, Rainer WG, Rapaport E, Rial WY, Saunders E, Ullyot DJ, Weg JG. Ethics in Cardiovascular medicine. Task Force II: The relation of cardiovascular specialists to patients, other physicians and physician-owned organizations. J Am Coll Cardiol 1990;16:11-16.
Wisniowski P, Pasula R, Martin WJ. Isolation of Pneumocystis carinii gp120 by fibronectin affinity: evidence for manganese dependency. Am J Respir Cell Mol Biol 1994;11:262-9.
Witte MH, Borgs P, Way DL, Bernas M, Ramirez G Jr, Witte CL. Kaposi's sarcoma vascular permeability, and scientific integrity. Comment on: Science 1992;255;1437-40; Comment in: JAMA 1994;272:916-924. JAMA 1994;271:1769-71.
Witte MH, Borgs P, Way LD, Ramirez G Jr., Witte CL, Bernas MJ. AIDS, alcohol, endothelium, and immunity. Alcohol 1994;11:91-7.
Wong VK, Gillette SG, Roth MJ, Miles S, Stiehm ER. Plasma immunotherapy in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1993;12:947-951.
Wong WY, Powars DR, Operskalski EA, Hassett J, Parker JW, Sarnaik SA, Pegelow CH, Hilgartner MW, Johnson CS, Zhou Y, Ku PY, Mosley JW, Transfusion Study Group. Blood transfusions and immunophenotypic alterations of lymphocyte subsets in sickle cell anemia. Blood 1995;35:2091-7.
Wright TW, Simpson-Haidaris PJ, Gigliotti F, Harmsen AG, Haidaris CG. Conserved sequence homology of cysteine-rich regions in genes encoding glycoprotein A in Pneumocystis carinii derived from different host species. Infect Immun 1994;62:1513-9.
Wu AY, Forouhar F, Cartun RW, Berman MM, Shiue ST, Louie AT, Grunnet M. Identification of human immunodeficiency virus in the heart of a patient with acquired immunodeficiency syndrome. Mod Pathol 1990;3:625-630.
Wu TC, Pizzorno MC, Hayward HS, Willoughby S, Neumann DA, Rose NR, Ansari AA, Beschorner WE, Baughman KL, Herskowitz A. In situ detection of human cytomegalovirus immediate-early gene transcripts within cardiac myocytes of patients with HIV-associated cardiomyopathy. AIDS 1992;6:777-785.
Yang G, Garhwal S, Olson JC, Vyas GN. Flow cytometric immunodetection of human immunodeficiency virus type 1 proviral DNA by heminested PCR and digoxigenin-labeled probes. Clin Diag Lab Immunol 1994;1:26-31.
Yolken RH, Sierra-Honigmann AM, Viscidi RP. Solid phase capture method for the specific amplification of microbial nucleic acids -- avoidance of false-positive and false-negative reactions. Molecular and Cellular Probes 1991;5:151-156.
Yu XF, Matsuda M, Essex M, Lee TH. Open reading frame vpr of simian immunodeficiency virus encodes a virion-associated protein. J Virol 1990;64:5688-5693.
Yu XF, Yu QC, Essex M, Lee TH. The vpx gene of Simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophages. J Virol 1991;65:5088-5091.
Yuan X, Matsuda Z, Matsuda M, Essex M, Lee TH. Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res and Hum Retroviruses 1990;6:1265-1271.
Zauli G, Re MC, Davis B, Sen L, Visani G, Gugliotta L, Furlini G, La Placa M. Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood 1992;79:2680-2687.
Zhang H, Bagasra O, Niikura M, Poiesz BJ, Pomerantz RJ. Intravirion reverse transcripts in the peripheral blood plasma of HIV-1 infected individuals. J Virol 1994;68:7591-7.
Zhang H, Zang Y, Spicer TP, Abbott LZ, Abbott M, Poiesz BJ. Reverse transcription takes place within extracellular HIV-I virions: Potential biological significance. Aids Res Hum Retro 1993;9:1287-96.
Zhang H, Zhang YH, Spicer T, Poiesz BJ. Nascent human immunodeficiency virus type I reverse transcription occurs within an enveloped particle. J Virol 1994;69:3675-82.
Zhang Y, Broser M, Cohen H, Bodkin M, Law K, Reibman J, Rom WN. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest 1995;95:586-592.
Zhu J, Cohen DA, Goud SN, Kaplan AM. Contribution of T lymphocytes to the development of bleomycin-induced pulmonary fibrosis. Ann NY Acad Sci 1996;796:194-202.
Zhu Z, Hitchcock MJM, Sommadossi JP. Metabolism and DNA interaction of 2',3'-didehydro-2',3'-dideoxythymidine (D4T) in human bone marrow cells. Molec Pharmacol 1991;40:838-845.
Zimmerman PE. Respiratory infections: a scientific basis for management. WB Saunders, Philadelphia, PA, 1994;439-448.
Zuck TF, Thomson RA, Schreiber GB, Gilcher RO, Kleinman SH, Murphy EL, Ownby HE, Williams AE, Busch MP, Smith JW, Nass CC, Hollingsworth CG, Nemo GJ for the REDS Group. The Retrovirus Epidemiology Donor Study (REDS): rationale and methods. Transfusion 1995;35:944-951.